Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUSRE43399 E1
Publication typeGrant
Application numberUS 12/139,305
Publication date22 May 2012
Filing date13 Jun 2008
Priority date25 Jul 2003
Fee statusPaid
Also published asEP1649260A2, EP1649260A4, US7074307, US20050115832, US20120228134, US20140001042, WO2005012873A2, WO2005012873A3
Publication number12139305, 139305, US RE43399 E1, US RE43399E1, US-E1-RE43399, USRE43399 E1, USRE43399E1
InventorsPeter C. Simpson, James R. Petisce, Victoria E. Carr-Brendel, James H. Brauker
Original AssigneeDexcom, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Electrode systems for electrochemical sensors
US RE43399 E1
Abstract
The present invention relates generally to systems and methods for improved electrochemical measurement of analytes. The preferred embodiments employ electrode systems including an analyte-measuring electrode for measuring the analyte or the product of an enzyme reaction with the analyte and an auxiliary electrode configured to generate oxygen and/or reduce electrochemical interferants. Oxygen generation by the auxiliary electrode advantageously improves oxygen availability to the enzyme and/or counter electrode; thereby enabling the electrochemical sensors of the preferred embodiments to function even during ischemic conditions. Interferant modification by the auxiliary electrode advantageously renders them substantially non-reactive at the analyte-measuring electrode, thereby reducing or eliminating inaccuracies in the analyte signal due to electrochemical interferants.
Images(5)
Previous page
Next page
Claims(152)
1. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material that is directly impermeable to glucose but is permeable to oxygen.
2. The electrochemical sensor of claim 1, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
3. The electrochemical sensor of claim 1, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
4. The electrochemical sensor of claim 1, wherein the polymer comprises a material that is permeable to interfering species.
5. The electrochemical sensor of claim 4, wherein the polymer comprises a material having a molecular weight that allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
6. The electrochemical sensor of claim 1, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
7. The electrochemical sensor of claim 1, wherein the auxiliary electrode is configured to electrochemically modify an electrochemical interferant interferent to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.
8. The electrochemical sensor of claim 7, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
9. The electrochemical sensor of claim 1, configured for measuring a concentration of glucose in a fluid.
10. The electrochemical sensor of claim 1, configured for insertion into a subcutaneous tissue of a host.
11. The electrochemical sensor of claim 1, configured for implantation into a subcutaneous tissue of a host.
12. The electrochemical sensor of claim 1, configured for measuring a concentration of glucose substantially without an oxygen deficit.
13. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is directly situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material that is impermeable to glucose but is permeable to oxygen and permeable to interfering species.
14. The electrochemical sensor of claim 13, wherein the polymer comprises a material having a molecular weight that blocks glucose and allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
15. The electrochemical sensor of claim 13, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
16. The electrochemical sensor of claim 13, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
17. The electrochemical sensor of claim 13, wherein the polymer comprises a material having a molecular weight that allows transport therethrough of urate, ascorbate, and acetaminophen.
18. The electrochemical sensor of claim 13, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
19. The electrochemical sensor of claim 13, wherein the auxiliary electrode is configured to electrochemically modify an electrochemical interferant interferent to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.
20. The electrochemical sensor of claim 19, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
21. The electrochemical sensor of claim 13, configured for measuring a concentration of glucose in a fluid.
22. The electrochemical sensor of claim 13, configured for insertion into a subcutaneous tissue of a host.
23. The electrochemical sensor of claim 13, configured for implantation into a subcutaneous tissue of a host.
24. The electrochemical sensor of claim 13, configured for measuring a concentration of glucose substantially without an oxygen deficit.
25. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to modify an electrochemical interferant interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material that is impermeable to glucose but is permeable to oxygen.
26. The electrochemical sensor of claim 25, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
27. The electrochemical sensor of claim 25, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
28. The electrochemical sensor of claim 25, wherein the polymer comprises a material that is permeable to an electrochemical interferant interferent.
29. The electrochemical sensor of claim 25, wherein the polymer comprises a material that is impermeable to glucose but is permeable to oxygen and interferants interferents.
30. The electrochemical sensor of claim 25, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1V.
31. The electrochemical sensor of claim 25, wherein the auxiliary electrode is configured to generate oxygen.
32. The electrochemical sensor of claim 31, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
33. The electrochemical sensor of claim 25, configured for measuring a concentration of glucose in a fluid.
34. The electrochemical sensor of claim 25, configured for insertion into a subcutaneous tissue of a host.
35. The electrochemical sensor of claim 25, configured for implantation into a subcutaneous tissue of a host.
36. The electrochemical sensor of claim 25, configured for measuring a concentration of glucose substantially without an oxygen deficit.
37. The electrochemical sensor of claim 25, wherein the auxiliary electrode is configured to generate oxygen.
38. The electrochemical sensor of claim 37, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
39. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to modify an electrochemical interferant interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material having a molecular weight that blocks glucose and allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
40. The electrochemical sensor of claim 39, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
41. The electrochemical sensor of claim 39, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
42. The electrochemical sensor of claim 39, wherein the polymer comprises a material that is permeable to an electrochemical interferant interferent.
43. The electrochemical sensor of claim 39, wherein the polymer comprises a material that is permeable to interferants interferents.
44. The electrochemical sensor of claim 39, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1V.
45. The electrochemical sensor of claim 39, wherein the auxiliary electrode is configured to generate oxygen.
46. The electrochemical sensor of claim 45, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
47. The electrochemical sensor of claim 39, configured for measuring a concentration of glucose in a fluid.
48. The electrochemical sensor of claim 39, configured for insertion into a subcutaneous tissue of a host.
49. The electrochemical sensor of claim 39, configured for implantation into a subcutaneous tissue of a host.
50. The electrochemical sensor of claim 39, configured for measuring a concentration of glucose substantially without an oxygen deficit.
51. An electrochemical sensor for measuring a concentration of an analyte in a biological fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material that is permeable or impermeable to glucose but is permeable to oxygen, and wherein the sensor is configured such that the auxiliary electrode is located between the electroactive surface of the working electrode and the biological fluid being measured.
52. The electrochemical sensor of claim 51, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
53. The electrochemical sensor of claim 51, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
54. The electrochemical sensor of claim 51, wherein the polymer comprises a material having a molecular weight that allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
55. The electrochemical sensor of claim 51, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
56. The electrochemical sensor of claim 51, wherein the auxiliary electrode is configured to electrochemically modify an electrochemical interferent to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.
57. The electrochemical sensor of claim 56, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
58. The electrochemical sensor of claim 51, configured for measuring a concentration of glucose in a fluid.
59. The electrochemical sensor of claim 51, configured for measuring a concentration of glucose substantially without an oxygen deficit.
60. An electrochemical sensor for measuring a concentration of an analyte in a biological fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated at a location directly between the electroactive surface and the biological fluid being measured such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is directly situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material that is permeable or impermeable to glucose but is permeable to oxygen and permeable to one or more interfering species.
61. The electrochemical sensor of claim 60, wherein the polymer comprises a material having a molecular weight that blocks glucose and allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
62. The electrochemical sensor of claim 60, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
63. The electrochemical sensor of claim 60, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
64. The electrochemical sensor of claim 60, wherein the polymer comprises a material having a molecular weight that allows transport therethrough of urate, ascorbate, and acetaminophen.
65. The electrochemical sensor of claim 60, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
66. The electrochemical sensor of claim 60, wherein the auxiliary electrode is configured to electrochemically modify an electrochemical interferent to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.
67. The electrochemical sensor of claim 66, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
68. The electrochemical sensor of claim 60, configured for measuring a concentration of glucose in a fluid.
69. The electrochemical sensor of claim 60, configured for insertion into a subcutaneous tissue of a host.
70. The electrochemical sensor of claim 60, configured for implantation into a subcutaneous tissue of a host.
71. The electrochemical sensor of claim 60, configured for measuring a concentration of glucose substantially without an oxygen deficit.
72. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to modify an electrochemical interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode such that at least a portion of the polymer is located more distal to the electroactive surface than the auxiliary electrode, and wherein the polymer comprises a material that is permeable or impermeable to glucose but is permeable to oxygen.
73. The electrochemical sensor of claim 72, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
74. The electrochemical sensor of claim 72, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
75. The electrochemical sensor of claim 72, wherein the polymer comprises a material that is permeable to an electrochemical interferent.
76. The electrochemical sensor of claim 72, wherein the polymer comprises a material that is impermeable to glucose but is permeable to oxygen and interferents.
77. The electrochemical sensor of claim 72, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
78. The electrochemical sensor of claim 72, wherein the auxiliary electrode is configured to generate oxygen.
79. The electrochemical sensor of claim 78, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
80. The electrochemical sensor of claim 72, configured for measuring a concentration of glucose in a fluid.
81. The electrochemical sensor of claim 72, configured for insertion into a subcutaneous tissue of a host.
82. The electrochemical sensor of claim 72, configured for implantation into a subcutaneous tissue of a host.
83. The electrochemical sensor of claim 72, configured for measuring a concentration of glucose substantially without an oxygen deficit.
84. The electrochemical sensor of claim 72, wherein the auxiliary electrode is configured to generate oxygen.
85. The electrochemical sensor of claim 84, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
86. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to modify an electrochemical interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode, wherein the auxiliary electrode located within or adjacent to a membrane system such that at least a portion of the membrane system is located more distal to the electroactive surface than the auxiliary electrode, and wherein the membrane system comprises a polymer comprising a material having a molecular weight that allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
87. The electrochemical sensor of claim 86, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
88. The electrochemical sensor of claim 86, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
89. The electrochemical sensor of claim 86, wherein the polymer comprises a material that is permeable to an electrochemical interferent.
90. The electrochemical sensor of claim 86, wherein the polymer comprises a material that is permeable to interferents.
91. The electrochemical sensor of claim 86, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
92. The electrochemical sensor of claim 86, wherein the auxiliary electrode is configured to generate oxygen.
93. The electrochemical sensor of claim 92, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
94. The electrochemical sensor of claim 86, configured for measuring a concentration of glucose in a fluid.
95. The electrochemical sensor of claim 86, configured for insertion into a subcutaneous tissue of a host.
96. The electrochemical sensor of claim 86, configured for implantation into a subcutaneous tissue of a host.
97. The electrochemical sensor of claim 86, configured for measuring a concentration of glucose substantially without an oxygen deficit.
98. An electrochemical sensor for measuring a concentration of an analyte in a biological fluid in a host, the sensor comprising:
a membrane system comprising: a cell impermeable domain configured to contact a biological fluid in a host and an enzyme domain comprising enzyme, wherein the enzyme reacts with the analyte;
a working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode located within or adjacent to the membrane system and comprising a conductive material and configured to modify an electrochemical interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode.
99. The sensor of claim 98, configured for measuring a concentration of glucose in a host.
100. The sensor of claim 98, configured for insertion into contact with a subcutaneous tissue of a host.
101. The sensor of claim 98, configured for communication with the intravascular system of a host.
102. The sensor of claim 98, configured for continuous measurement of the analyte in a host.
103. The sensor of claim 98, further comprising a potentiostat operably connected to the working electrode.
104. The sensor of claim 103, wherein the potentiostat enables continuous measurement of the analyte in a host.
105. The sensor of claim 98, further comprising sensor electronics operably connected to the working electrode, wherein the sensor electronics are configured to transmit data to a receiver.
106. The sensor of claim 105, wherein the sensor electronics comprise an RF transceiver configured to wirelessly transmit the data to a receiver.
107. The sensor of claim 98, wherein the membrane system is configured to limit diffusion of the analyte there through.
108. The sensor of claim 107, wherein the membrane system further comprises a resistance domain configured to limit diffusion of the analyte there through.
109. The sensor of claim 98, wherein the membrane system is configured to limit or block one or more interfering species there through.
110. The sensor of claim 109, wherein the membrane system further comprises an interference domain configured to limit or block the one or more interfering species there through.
111. The sensor of claim 109, wherein the membrane system further comprises an electrolyte domain configured to provide the hydrophilicity at the working electrode.
112. The sensor of claim 98, wherein the membrane system is configured to provide a hydrophilicity at the working electrode.
113. The sensor of claim 98, wherein the cell impermeable domain is located more distal from the working electrode than any other domain of the membrane system such that the cell impermeable domain directly contacts the host when placed into contact with the host's dermis, subcutaneous tissue and/or intravascular system.
114. The sensor of claim 98, wherein the auxiliary electrode is located within the cell impermeable domain.
115. The sensor of claim 98, wherein the auxiliary electrode is located between the cell impermeable domain and the enzyme domain.
116. An electrochemical sensor for continuous measurement of a concentration of an analyte in an in vivo biological environment, the sensor comprising:
a membrane comprising an outermost layer configured for protection of the sensor from the biological environment, wherein the membrane further comprises an enzyme configured to react with the analyte;
a working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode located within or adjacent to the membrane and comprising a conductive material, wherein the auxiliary electrode is configured to modify an electrochemical interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode.
117. The sensor of claim 116, configured for measuring a concentration of glucose in a host.
118. The sensor of claim 116, configured for insertion into contact with a subcutaneous tissue of a host.
119. The sensor of claim 116, configured for communication with the intravascular system of a host.
120. The sensor of claim 116, further comprising a potentiostat operably connected to the working electrode.
121. The sensor of claim 120, wherein the potentiostat enables continuous measurement of the analyte in a host.
122. The sensor of claim 116, further comprising sensor electronics operably connected to the working electrode, wherein the sensor electronics are configured to transmit data to a receiver.
123. The sensor of claim 122, wherein the sensor electronics comprise an RF transceiver configured to wirelessly transmit the data to a receiver.
124. The sensor of claim 116, wherein the membrane is configured to limit diffusion of the analyte there through.
125. The sensor of claim 124, wherein the membrane further comprises a resistance domain configured to limit diffusion of the analyte there through.
126. The sensor of claim 116, wherein the membrane is configured to limit or block one or more interfering species there through.
127. The sensor of claim 126, wherein the membrane further comprises an interference domain configured to limit or block the one or more interfering species there through.
128. The sensor of claim 116, wherein the membrane is configured to provide a hydrophilicity at the working electrode.
129. The sensor of claim 128, wherein the membrane further comprises an electrolyte domain configured to provide the hydrophilicity at the working electrode.
130. The sensor of claim 116, wherein the cell impermeable domain is located more distal from the working electrode than any other domain of the membrane such that the cell impermeable domain directly contacts the host when placed into contact with the host's dermis, subcutaneous tissue and/or intravascular system.
131. The sensor of claim 116, wherein the auxiliary electrode is located within the outermost layer.
132. The sensor of claim 116, wherein the auxiliary electrode is located between the outermost layer and the enzyme.
133. An electrochemical sensor for measuring a concentration of an analyte in a biological fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with an analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of a reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, wherein the polymer comprises a material that is permeable or impermeable to glucose but is permeable to oxygen, and wherein the sensor is configured such that the auxiliary electrode is located between the electroactive surface of the working electrode and a biological fluid in which a concentration of the analyte is being measured;
wherein the sensor is configured for insertion or implantation into a subcutaneous tissue of a host.
134. The electrochemical sensor of claim 133, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
135. The electrochemical sensor of claim 133, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
136. The electrochemical sensor of claim 133, wherein the polymer comprises a material that is permeable to interfering species.
137. The electrochemical sensor of claim 136, wherein the polymer comprises a material having a molecular weight that allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
138. The electrochemical sensor of claim 133, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
139. The electrochemical sensor of claim 133, wherein the auxiliary electrode is configured to electrochemically modify an electrochemical interferent to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.
140. The electrochemical sensor of claim 139, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
141. The electrochemical sensor of claim 133, configured for measuring a concentration of glucose in a fluid.
142. The electrochemical sensor of claim 133, configured for measuring a concentration of glucose substantially without an oxygen deficit.
143. An electrochemical sensor for measuring a concentration of an analyte in a biological fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with an analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of a reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, wherein the polymer comprises a material that is permeable or impermeable to glucose but is permeable to oxygen, wherein the polymer comprises a material that is permeable to interfering species, and wherein the sensor is configured such that the auxiliary electrode is located between the electroactive surface of the working electrode and a biological fluid in which a concentration of the analyte is being measured.
144. The electrochemical sensor of claim 143, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
145. The electrochemical sensor of claim 143, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
146. The electrochemical sensor of claim 143, wherein the polymer comprises a material that is permeable to interfering species.
147. The electrochemical sensor of claim 146, wherein the polymer comprises a material having a molecular weight that allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
148. The electrochemical sensor of claim 143, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
149. The electrochemical sensor of claim 143, wherein the auxiliary electrode is configured to electrochemically modify an electrochemical interferent to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.
150. The electrochemical sensor of claim 149, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
151. The electrochemical sensor of claim 143, configured for measuring a concentration of glucose in a fluid.
152. The electrochemical sensor of claim 143, configured for measuring a concentration of glucose substantially without an oxygen deficit.
Description
RELATED APPLICATION

This application claims the benefit of priority under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 60/490,007, filed Jul. 25, 2003, the contents of which are hereby incorporated by reference in their entirety.

FIELD OF THE INVENTION

The present invention relates generally to systems and methods for improving electrochemical sensor performance.

BACKGROUND OF THE INVENTION

Electrochemical sensors are useful in chemistry and medicine to determine the presence or concentration of a biological analyte. Such sensors are useful, for example, to monitor glucose in diabetic patients and lactate during critical care events.

Diabetes mellitus is a disorder in which the pancreas cannot create sufficient insulin (Type I or insulin dependent) and/or in which insulin is not effective (Type 2 or non-insulin dependent). In the diabetic state, the victim suffers from high blood sugar, which causes an array of physiological derangements (kidney failure, skin ulcers, or bleeding into the vitreous of the eye) associated with the deterioration of small blood vessels. A hypoglycemic reaction (low blood sugar) is induced by an inadvertent overdose of insulin, or after a normal dose of insulin or glucose-lowering agent accompanied by extraordinary exercise or insufficient food intake.

Conventionally, a diabetic person carries a self-monitoring blood glucose (SMBG) monitor, which typically comprises uncomfortable finger pricking methods. Due to the lack of comfort and convenience, a diabetic will normally only measure his or her glucose level two to four times per day. Unfortunately, these time intervals are spread apart so far that the diabetic will likely find out too late, sometimes incurring dangerous side effects, of a hyperglycemic or hypoglycemic condition. It is not only unlikely that a diabetic will take a timely SMBG value, but additionally the diabetic will not know if their blood glucose value is going up (higher) or down (lower) based on conventional methods.

Consequently, a variety of transdermal and implantable electrochemical sensors are being developed for continuously detecting and/or quantifying blood glucose values. Many implantable glucose sensors suffer from complications within the body and provide only short-term or less-than-accurate working of blood glucose. Similarly, transdermal sensors have problems in accurately working and reporting back glucose values continuously over extended periods of time. Some efforts have been made to obtain blood glucose data from implantable devices and retrospectively determine blood glucose trends for analysis; however these efforts do not aid the diabetic in determining real-time blood glucose information. Some efforts have also been made to obtain blood glucose data from transdermal devices for prospective data analysis, however similar problems have occurred.

SUMMARY OF THE PREFERRED EMBODIMENTS

In contrast to the prior art, the sensors of preferred embodiments advantageously generate oxygen to allow the sensor to function at sufficient oxygen levels independent of the oxygen concentration in the surrounding environment. In another aspect of the preferred embodiments, systems and methods for modifying electrochemical interferants are provided.

Accordingly, in a first embodiment, an electrochemical sensor for determining a presence or a concentration of an analyte in a fluid is provided, the sensor comprising a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte; an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface.

In an aspect of the first embodiment, the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.

In an aspect of the first embodiment, the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.

In an aspect of the first embodiment, the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode.

In an aspect of the first embodiment, the polymer comprises a material that is impermeable to glucose but is permeable to oxygen.

In an aspect of the first embodiment, the polymer comprises a material that is impermeable to glucose but is permeable to oxygen and permeable to interfering species.

In an aspect of the first embodiment, the polymer comprises a material having a molecular weight that blocks glucose and allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.

In an aspect of the first embodiment, the polymer comprises a material that is permeable to glucose and oxygen.

In an aspect of the first embodiment, the polymer comprises a material that is permeable to glucose, oxygen, and interfering species.

In an aspect of the first embodiment, the polymer comprises a material having a molecular weight that allows transport therethrough of oxygen, glucose, urate, ascorbate, and acetaminophen.

In an aspect of the first embodiment, the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.

In an aspect of the first embodiment, the auxiliary electrode is configured to electrochemically modify an electrochemical interferant to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.

In an aspect of the first embodiment, the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.

In a second embodiment, an electrochemical sensor for determining a presence or a concentration of an analyte in a fluid is provided, the sensor comprising a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte; an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and an auxiliary electrode comprising a conductive material and configured to modify an electrochemical interferant such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode.

In an aspect of the second embodiment, the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.

In an aspect of the second embodiment, the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.

In an aspect of the second embodiment, the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode.

In an aspect of the second embodiment, the polymer comprises a material that is permeable to an electrochemical interferant.

In an aspect of the second embodiment, the polymer comprises a material that is impermeable to glucose but is permeable to oxygen.

In an aspect of the second embodiment, the polymer comprises a material that is impermeable to glucose but is permeable to oxygen and interferants.

In an aspect of the second embodiment, the polymer comprises a material having a molecular weight that blocks glucose and allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.

In an aspect of the second embodiment, the polymer comprises a material that is permeable to glucose and oxygen.

In an aspect of the second embodiment, the polymer comprises a material that is permeable to glucose, oxygen, and interferants.

In an aspect of the second embodiment, the polymer comprises a material having a molecular weight that allows transport therethrough of oxygen, glucose, urate, ascorbate, and acetaminophen.

In an aspect of the second embodiment, the auxiliary electrode is configured to be set at a potential of at least about +0.1V.

In an aspect of the second embodiment, the auxiliary electrode is configured to generate oxygen.

In an aspect of the second embodiment, the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.

In a third embodiment, an electrochemical sensor is provided comprising an electroactive surface configured to measure an analyte; and an auxiliary interferant-modifying electrode configured to modify an electrochemical interferant such that the electrochemical interferant is rendered substantially non-reactive at the electroactive surface.

In an aspect of the third embodiment, the auxiliary interferant-modifying electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.

In an aspect of the third embodiment, the auxiliary interferant-modifying electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.

In an aspect of the third embodiment, the auxiliary interferant-modifying electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary interferant-modifying electrode.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is an exploded perspective view of one exemplary embodiment of a implantable glucose sensor.

FIG. 2 is a block diagram that illustrates sensor electronics in one exemplary embodiment.

FIG. 3 is a graph that shows a raw data stream obtained from a glucose sensor without an auxiliary electrode of the preferred embodiments.

FIG. 4 is a side schematic illustration of a portion of an electrochemical sensor of the preferred embodiments, showing an auxiliary electrode placed proximal to the enzyme domain within a membrane system.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

The following description and examples illustrate some exemplary embodiments of the disclosed invention in detail. Those of skill in the art will recognize that there are numerous variations and modifications of this invention that are encompassed by its scope. Accordingly, the description of a certain exemplary embodiment should not be deemed to limit the scope of the present invention.

Definitions

In order to facilitate an understanding of the preferred embodiments, a number of terms are defined below.

The term “analyte” as used herein is a broad term and is used in its ordinary sense, including, without limitation, to refer to a substance or chemical constituent in a biological fluid (for example, blood, interstitial fluid, cerebral spinal fluid, lymph fluid or urine) that can be analyzed. Analytes can include naturally occurring substances, artificial substances, metabolites, and/or reaction products. In some embodiments, the analyte for measurement by the sensing regions, devices, and methods is glucose. However, other analytes are contemplated as well, including but not limited to acarboxyprothrombin; acylcarnitine; adenine phosphoribosyl transferase; adenosine deaminase; albumin; alpha-fetoprotein; amino acid profiles (arginine (Krebs cycle), histidine/urocanic acid, homocysteine, phenylalanine/tyrosine, tryptophan); andrenostenedione; antipyrine; arabinitol enantiomers; arginase; benzoylecgonine (cocaine); biotinidase; biopterin; c-reactive protein; carnitine; carnosinase; CD4; ceruloplasmin; chenodeoxycholic acid; chloroquine; cholesterol; cholinesterase; conjugated 1-β hydroxy-cholic acid; cortisol; creatine kinase; creatine kinase MM isoenzyme; cyclosporin A; d-penicillamine; de-ethylchloroquine; dehydroepiandrosterone sulfate; DNA (acetylator polymorphism, alcohol dehydrogenase, alpha 1-antitrypsin, cystic fibrosis, Duchenne/Becker muscular dystrophy, glucose-6-phosphate dehydrogenase, hemoglobin A, hemoglobin S, hemoglobin C, hemoglobin D, hemoglobin E, hemoglobin F, D-Punjab, beta-thalassemia, hepatitis B virus, HCMV, HIV-1, HTLV-1, Leber hereditary optic neuropathy, MCAD, RNA, PKU, Plasmodium vivax, sexual differentiation, 21-deoxycortisol); desbutylhalofantrine; dihydropteridine reductase; diptheria/tetanus antitoxin; erythrocyte arginase; erythrocyte protoporphyrin; esterase D; fatty acids/acylglycines; free β-human chorionic gonadotropin; free erythrocyte porphyrin; free thyroxine (FT4); free tri-iodothyronine (FT3); fumarylacetoacetase; galactose/gal-1-phosphate; galactose-1-phosphate uridyltransferase; gentamicin; glucose-6-phosphate dehydrogenase; glutathione; glutathione perioxidase; glycocholic acid; glycosylated hemoglobin; halofantrine; hemoglobin variants; hexosaminidase A; human erythrocyte carbonic anhydrase I; 17-alpha-hydroxyprogesterone; hypoxanthine phosphoribosyl transferase; immunoreactive trypsin; lactate; lead; lipoproteins ((a), B/A-1, β); lysozyme; mefloquine; netilmicin; phenobarbitone; phenytoin; phytanic/pristanic acid; progesterone; prolactin; prolidase; purine nucleoside phosphorylase; quinine; reverse tri-iodothyronine (rT3); selenium; serum pancreatic lipase; sissomicin; somatomedin C; specific antibodies (adenovirus, anti-nuclear antibody, anti-zeta antibody, arbovirus, Aujeszky's disease virus, dengue virus, Dracunculus medinensis, Echinococcus granulosus, Entamoeba histolytica, enterovirus, Giardia duodenalisa, Helicobacter pylori, hepatitis B virus, herpes virus, HIV-1, IgE (atopic disease), influenza virus, Leishmania donovani, leptospira, measles/mumps/rubella, Mycobacterium leprae, Mycoplasma pneumoniae, Myoglobin, Onchocerca volvulus, parainfluenza virus, Plasmodium falciparum, poliovirus, Pseudomonas aeruginosa, respiratory syncytial virus, rickettsia (scrub typhus), Schistosoma mansoni, Toxoplasma gondii, Trepenoma pallidium, Trypanosoma cruzi/rangeli, vesicular stomatis virus, Wuchereria bancrofti, yellow fever virus); specific antigens (hepatitis B virus, HIV-1); succinylacetone; sulfadoxine; theophylline; thyrotropin (TSH); thyroxine (T4); thyroxine-binding globulin; trace elements; transferrin; UDP-galactose-4-epimerase; urea; uroporphyrinogen I synthase; vitamin A; white blood cells; and zinc protoporphyrin. Salts, sugar, protein, fat, vitamins and hormones naturally occurring in blood or interstitial fluids can also constitute analytes in certain embodiments. The analyte can be naturally present in the biological fluid or endogenous, for example, a metabolic product, a hormone, an antigen, an antibody, and the like. Alternatively, the analyte can be introduced into the body or exogenous, for example, a contrast agent for imaging, a radioisotope, a chemical agent, a fluorocarbon-based synthetic blood, or a drug or pharmaceutical composition, including but not limited to insulin; ethanol; cannabis (marijuana, tetrahydrocannabinol, hashish); inhalants (nitrous oxide, amyl nitrite, butyl nitrite, chlorohydrocarbons, hydrocarbons); cocaine (crack cocaine); stimulants (amphetamines, methamphetamines, Ritalin, Cylert, Preludin, Didrex, PreState, Voranil, Sandrex, Plegine); depressants (barbituates, methaqualone, tranquilizers such as Valium, Librium, Miltown, Serax, Equanil, Tranxene); hallucinogens (phencyclidine, lysergic acid, mescaline, peyote, psilocybin); narcotics (heroin, codeine, morphine, opium, meperidine, Percocet, Percodan, Tussionex, Fentanyl, Darvon, Talwin, Lomotil); designer drugs (analogs of fentanyl, meperidine, amphetamines, methamphetamines, and phencyclidine, for example, Ecstasy); anabolic steroids; and nicotine. The metabolic products of drugs and pharmaceutical compositions are also contemplated analytes. Analytes such as neurochemicals and other chemicals generated within the body can also be analyzed, such as, for example, ascorbic acid, uric acid, dopamine, noradrenaline, 3-methoxytyramine (3MT), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 5-hydroxytryptamine (5HT), and 5-hydroxyindoleacetic acid (FHIAA).

The terms “operable connection,” “operably connected,” and “operably linked” as used herein are broad terms and are used in their ordinary sense, including, without limitation, one or more components linked to another component(s) in a manner that allows transmission of signals between the components. For example, one or more electrodes can be used to detect the amount of analyte in a sample and convert that information into a signal; the signal can then be transmitted to a circuit. In this case, the electrode is “operably linked” to the electronic circuitry.

The term “host” as used herein is a broad term and is used in its ordinary sense, including, without limitation, mammals, particularly humans.

The term “sensor,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, the portion or portions of an analyte-monitoring device that detects an analyte. In one embodiment, the sensor includes an electrochemical cell that has a working electrode, a reference electrode, and optionally a counter electrode passing through and secured within the sensor body forming an electrochemically reactive surface at one location on the body, an electronic connection at another location on the body, and a membrane system affixed to the body and covering the electrochemically reactive surface. During general operation of the sensor, a biological sample (for example, blood or interstitial fluid), or a portion thereof, contacts (directly or after passage through one or more membranes or domains) an enzyme (for example, glucose oxidase); the reaction of the biological sample (or portion thereof) results in the formation of reaction products that allow a determination of the analyte level in the biological sample.

The term “signal output,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, an analog or digital signal directly related to the measured analyte from the analyte-measuring device. The term broadly encompasses a single point, or alternatively, a plurality of time spaced data points from a substantially continuous glucose sensor, which comprises individual measurements taken at time intervals ranging from fractions of a second up to, for example, 1, 2, or 5 minutes or longer.

The term “electrochemical cell,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, a device in which chemical energy is converted to electrical energy. Such a cell typically consists of two or more electrodes held apart from each other and in contact with an electrolyte solution. Connection of the electrodes to a source of direct electric current renders one of them negatively charged and the other positively charged. Positive ions in the electrolyte migrate to the negative electrode (cathode) and there combine with one or more electrons, losing part or all of their charge and becoming new ions having lower charge or neutral atoms or molecules; at the same time, negative ions migrate to the positive electrode (anode) and transfer one or more electrons to it, also becoming new ions or neutral particles. The overall effect of the two processes is the transfer of electrons from the negative ions to the positive ions, a chemical reaction.

The term “potentiostat,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, an electrical system that controls the potential between the working and reference electrodes of a three-electrode cell at a preset value independent of resistance changes between the electrodes. It forces whatever current is necessary to flow between the working and counter electrodes to keep the desired potential, as long as the cell voltage and current do not exceed the compliance limits of the potentiostat.

The terms “electrochemically reactive surface” and “electroactive surface” as used herein are broad terms and are used in their ordinary sense, including, without limitation, the surface of an electrode where an electrochemical reaction takes place. In one example, a working electrode measures hydrogen peroxide produced by the enzyme catalyzed reaction of the analyte being detected reacts creating an electric current (for example, detection of glucose analyte utilizing glucose oxidase produces H2O2 as a by product, H2O2 reacts with the surface of the working electrode producing two protons (2H+), two electrons (2e) and one molecule of oxygen (O2) which produces the electronic current being detected). In the case of the counter electrode, a reducible species, for example, O2 is reduced at the electrode surface in order to balance the current being generated by the working electrode.

The term “sensing region” as used herein is a broad term and is used in its ordinary sense, including, without limitation, the region of a monitoring device responsible for the detection of a particular analyte. The sensing region generally comprises a non-conductive body, a working electrode, a reference electrode, and optionally a counter electrode passing through and secured within the body forming electrochemically reactive surfaces on the body and an electronic connective means at another location on the body, and a multi-domain membrane system affixed to the body and covering the electrochemically reactive surface.

The terms “raw data stream” and “data stream,” as used herein, are broad terms and are used in their ordinary sense, including, without limitation, an analog or digital signal directly related to the measured an analyte from an analyte sensor. In one example, the raw data stream is digital data in “counts” converted by an A/D converter from an analog signal (for example, voltage or amps) representative of a analyte concentration. The terms broadly encompass a plurality of time spaced data points from a substantially continuous analyte sensor, which comprises individual measurements taken at time intervals ranging from fractions of a second up to, for example, 1, 2, or 5 minutes or longer.

The term “counts,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, a unit of measurement of a digital signal. In one example, a raw data stream measured in counts is directly related to a voltage (for example, converted by an A/D converter), which is directly related to current from the working electrode. In another example, counter electrode voltage measured in counts is directly related to a voltage.

The terms “electrical potential” and “potential” as used herein, are broad terms and are used in their ordinary sense, including, without limitation, the electrical potential difference between two points in a circuit which is the cause of the flow of a current.

The term “ischemia,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, local and temporary deficiency of blood supply due to obstruction of circulation to a part (for example, a sensor). Ischemia can be caused by mechanical obstruction (for example, arterial narrowing or disruption) of the blood supply, for example.

The term “system noise,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, unwanted electronic or diffusion-related noise which can include Gaussian, motion-related, flicker, kinetic, or other white noise, for example.

The terms “signal artifacts” and “transient non-glucose related signal artifacts that have a higher amplitude than system noise,” as used herein, are broad terms and are used in their ordinary sense, including, without limitation, signal noise that is caused by substantially non-glucose reaction rate-limiting phenomena, such as ischemia, pH changes, temperature changes, pressure, and stress, for example. Signal artifacts, as described herein, are typically transient and characterized by a higher amplitude than system noise.

The term “low noise,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, noise that substantially decreases signal amplitude.

The terms “high noise” and “high spikes,” as used herein, are broad terms and are used in their ordinary sense, including, without limitation, noise that substantially increases signal amplitude.

The phrase “distal to” as used herein is a broad term and is used in its ordinary sense, including, without limitation, the spatial relationship between various elements in comparison to a particular point of reference. For example, some embodiments of a device include a membrane system having a cell disruptive domain and a cell impermeable domain. If the sensor is deemed to be the point of reference and the cell disruptive domain is positioned farther from the sensor, then that domain is distal to the sensor.

The phrase “proximal to” as used herein is a broad term and is used in its ordinary sense, including, without limitation, the spatial relationship between various elements in comparison to a particular point of reference. For example, some embodiments of a device include a membrane system having a cell disruptive domain and a cell impermeable domain. If the sensor is deemed to be the point of reference and the cell impermeable domain is positioned nearer to the sensor, then that domain is proximal to the sensor.

The terms “interferants” and “interfering species,” as used herein, are broad terms and are used in their ordinary sense, including, but not limited to, effects and/or species that interfere with the measurement of an analyte of interest in a sensor to produce a signal that does not accurately represent the analyte measurement. In one example of an electrochemical sensor, interfering species are compounds with an oxidation potential that overlaps with the analyte to be measured.

As employed herein, the following abbreviations apply: Eq and Eqs (equivalents); mEq (milliequivalents); M (molar); mM (millimolar) μM (micromolar); N (Normal); mol (moles); mmol (millimoles); μmol (micromoles); nmol (nanomoles); g (grams); mg (milligrams); μg (micrograms); Kg (kilograms); L (liters); mL (milliliters); dL (deciliters); μL (microliters); cm (centimeters); mm (millimeters); μm (micrometers); nm (nanometers); h and hr (hours); min. (minutes); s and sec. (seconds); ° C. (degrees Centigrade).

Overview

The preferred embodiments relate to the use of an electrochemical sensor that measures a concentration of an analyte of interest or a substance indicative of the concentration or presence of the analyte in fluid. In some embodiments, the sensor is a continuous device, for example a subcutaneous, transdermal, or intravascular device. In some embodiments, the device can analyze a plurality of intermittent blood samples.

The sensor uses any known method, including invasive, minimally invasive, and non-invasive sensing techniques, to provide an output signal indicative of the concentration of the analyte of interest. The sensor is of the type that senses a product or reactant of an enzymatic reaction between an analyte and an enzyme in the presence of oxygen as a measure of the analyte in vivo or in vitro. Such a sensor typically comprises a membrane surrounding the enzyme through which a bodily fluid passes and in which an analyte within the bodily fluid reacts with an enzyme in the presence of oxygen to generate a product. The product is then measured using electrochemical methods and thus the output of an electrode system functions as a measure of the analyte. In some embodiments, the sensor can use an amperometric, coulometric, conductimetric, and/or potentiometric technique for measuring the analyte. In some embodiments, the electrode system can be used with any of a variety of known in vitro or in vivo analyte sensors or monitors.

FIG. 1 is an exploded perspective view of one exemplary embodiment of an implantable glucose sensor 10 that utilizes an electrode system 16. In this exemplary embodiment, a body with a sensing region 14 includes an electrode system (16a to 16c), also referred to as the electroactive sensing surface, and sensor electronics, which are described in more detail with reference to FIG. 2.

In this embodiment, the electrode system 16 is operably connected to the sensor electronics (FIG. 2) and includes electroactive surfaces (including two-, three- or more electrode systems), which are covered by a membrane system 18. The membrane system 18 is disposed over the electroactive surfaces of the electrode system 16 and provides one or more of the following functions: 1) protection of the exposed electrode surface from the biological environment (cell impermeable domain); 2) diffusion resistance (limitation) of the analyte (resistance domain); 3) a catalyst for enabling an enzymatic reaction (enzyme domain); 4) limitation or blocking of interfering species (interference domain); and/or 5) hydrophilicity at the electrochemically reactive surfaces of the sensor interface (electrolyte domain), for example, such as described in co-pending U.S. patent application Ser. No. 10/838,912, filed May 3, 2004 and entitled “IMPLANTABLE ANALYTE SENSOR,” the contents of which are incorporated herein by reference in their entirety. The membrane system can be attached to the sensor body by mechanical or chemical methods such as described in co-pending U.S. patent application Ser. No. 10/885,476, filed Jul. 6, 2004 and entitled, “SYSTEMS AND METHODS FOR MANUFACTURE OF AN ANALYTE-MEASURING DEVICE INCLUDING A MEMBRANE SYSTEM” and U.S. patent application Ser. No. 10/838,912 filed May 3, 2004 and entitled, “IMPLANTABLE ANALYTE SENSOR”, which are incorporated herein by reference in their entirety.

In the embodiment of FIG. 1, the electrode system 16 includes three electrodes (working electrode 16a, counter electrode 16b, and reference electrode 16c), wherein the counter electrode is provided to balance the current generated by the species being measured at the working electrode. In the case of a glucose oxidase based glucose sensor, the species measured at the working electrode is H2O2. Glucose oxidase, GOX, catalyzes the conversion of oxygen and glucose to hydrogen peroxide and gluconate according to the following reaction:
GOX+Glucose+O2→Gluconate+H2O2+reduced GOX

The change in H2O2 can be monitored to determine glucose concentration because for each glucose molecule metabolized, there is a proportional change in the product H2O2. Oxidation of H2O2 by the working electrode is balanced by reduction of ambient oxygen, enzyme generated H2O2, or other reducible species at the counter electrode. The H2O2 produced from the glucose oxidase reaction further reacts at the surface of working electrode and produces two protons (2H+), two electrons (2e−), and one oxygen molecule (O2). In such embodiments, because the counter electrode utilizes oxygen as an electron acceptor, the most likely reducible species for this system are oxygen or enzyme generated peroxide. There are two main pathways by which oxygen can be consumed at the counter electrode. These pathways include a four-electron pathway to produce hydroxide and a two-electron pathway to produce hydrogen peroxide. In addition to the counter electrode, oxygen is further consumed by the reduced glucose oxidase within the enzyme domain. Therefore, due to the oxygen consumption by both the enzyme and the counter electrode, there is a net consumption of oxygen within the electrode system. Theoretically, in the domain of the working electrode there is significantly less net loss of oxygen than in the region of the counter electrode. In some embodiments, there is a close correlation between the ability of the counter electrode to maintain current balance and sensor function.

In general, in electrochemical sensors wherein an enzymatic reaction depends on oxygen as a co-reactant, depressed function or inaccuracy can be experienced in low oxygen environments, for example in vivo. Subcutaneously implanted devices are especially susceptible to transient ischemia that can compromise device function; for example, because of the enzymatic reaction required for an implantable amperometric glucose sensor, oxygen must be in excess over glucose in order for the sensor to effectively function as a glucose sensor. If glucose becomes in excess, the sensor turns into an oxygen sensitive device. In vivo, glucose concentration can vary from about one hundred times or more that of the oxygen concentration. Consequently, one limitation of prior art enzymatic-based electrochemical analyte sensors can be caused by oxygen deficiencies, which is described in more detail with reference to FIG. 3.

FIG. 2 is a block diagram that illustrates sensor electronics in one exemplary embodiment; one skilled in the art appreciates however that a variety of sensor electronics configurations can be implemented with the preferred embodiments. In this embodiment, a potentiostat 20 is shown, which is operatively connected to electrode system 16 (FIG. 1) to obtain a current value, and includes a resistor (not shown) that translates the current into voltage. The A/D converter 21 digitizes the analog signal into “counts” for processing. Accordingly, the resulting raw data signal in counts is directly related to the current measured by the potentiostat.

A microprocessor 22 is the central control unit that houses EEPROM 23 and SRAM 24, and controls the processing of the sensor electronics. The alternative embodiments can utilize a computer system other than a microprocessor to process data as described herein. In some alternative embodiments, an application-specific integrated circuit (ASIC) can be used for some or all the sensor's central processing. EEPROM 23 provides semi-permanent storage of data, storing data such as sensor ID and necessary programming to process data signals (for example, programming for data smoothing such as described elsewhere herein). SRAM 24 is used for the system's cache memory, for example for temporarily storing recent sensor data.

The battery 25 is operatively connected to the microprocessor 22 and provides the necessary power for the sensor. In one embodiment, the battery is a Lithium Manganese Dioxide battery, however any appropriately sized and powered battery can be used. In some embodiments, a plurality of batteries can be used to power the system. Quartz crystal 26 is operatively connected to the microprocessor 22 and maintains system time for the computer system.

The RF Transceiver 27 is operably connected to the microprocessor 22 and transmits the sensor data from the sensor to a receiver. Although a RF transceiver is shown here, some other embodiments can include a wired rather than wireless connection to the receiver. In yet other embodiments, the sensor can be transcutaneously connected via an inductive coupling, for example. The quartz crystal 28 provides the system time for synchronizing the data transmissions from the RF transceiver. The transceiver 27 can be substituted with a transmitter in one embodiment.

Although FIGS. 1 and 2 and associated text illustrate and describe an exemplary embodiment of an implantable glucose sensor, the electrode systems of the preferred embodiments described below can be implemented with any known electrochemical sensor, including U.S. Pat. No. 6,001,067 to Shults et al.; U.S. Pat. No. 6,702,857 to Brauker et al.; U.S. Pat. No. 6,212,416 to Ward et al.; U.S. Pat. No. 6,119,028 to Schulman et al; U.S. Pat. No. 6,400,974 to Lesho; U.S. Pat. No. 6,595,919 to Berner et al.; U.S. Pat. No. 6,141,573 to Kurnik et al.; U.S. Pat. No. 6,122,536 to Sun et al.; European Patent Application EP 1153571 to Varall et al.; U.S. Pat. No. 6,512,939 to Colvin et al.; U.S. Pat. No. 5,605,152 to Slate et al.; U.S. Pat. No. 4,431,004 to Bessman et al.; U.S. Pat. No. 4,703,756 to Gough et al.; U.S. Pat. No. 6,514,718 to Heller et al; to U.S. Pat. No. 5,985,129 to Gough et al.; WO Patent Application Publication No. 2004/021877 to Caduff; U.S. Pat. No. 5,494,562 to Maley et al.; U.S. Pat. No. 6,120,676 to Heller et al.; and U.S. Pat. No. 6,542,765 to Guy et al., co-pending U.S. patent application Ser. No. 10/838,912 filed May 3, 2004 and entitled, “IMPLANTABLE ANALYTE SENSOR”; U.S. patent application Ser. No. 10/789,359 filed Feb. 26, 2004 and entitled, “INTEGRATED DELIVERY DEVICE FOR A CONTINUOUS GLUCOSE SENSOR”; “OPTIMIZED SENSOR GEOMETRY FOR AN IMPLANTABLE GLUCOSE SENSOR”; U.S. application Ser. No. 10/633,367 filed Aug. 1, 2003 entitled, “SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA,” the contents of each of which are incorporated herein by reference in their entirety.

FIG. 3 is a graph that depicts a raw data stream obtained from a prior art glucose sensor such as described with reference to FIG. 1. The x-axis represents time in minutes. The y-axis represents sensor data in counts. In this example, sensor output in counts is transmitted every 30-seconds. The raw data stream 30 includes substantially smooth sensor output in some portions, however other portions exhibit erroneous or transient non-glucose related signal artifacts 32. Particularly, referring to the signal artifacts 32, it is believed that effects of local ischemia on prior art electrochemical sensors creates erroneous (non-glucose) signal values due to oxygen deficiencies either at the enzyme within the membrane system and/or at the counter electrode on the electrode surface.

In one situation, when oxygen is deficient relative to the amount of glucose, then the enzymatic reaction is limited by oxygen rather than glucose. Thus, the output signal is indicative of the oxygen concentration rather than the glucose concentration, producing erroneous signals. Additionally, when an enzymatic reaction is rate-limited by oxygen, glucose is expected to build up in the membrane because it is not completely catabolized during the oxygen deficit. When oxygen is again in excess, there is also excess glucose due to the transient oxygen deficit. The enzyme rate then speeds up for a short period until the excess glucose is catabolized, resulting in spikes of non-glucose related increased sensor output. Accordingly, because excess oxygen (relative to glucose) is necessary for proper sensor function, transient ischemia can result in a loss of signal gain in the sensor data.

In another situation, oxygen deficiency can be seen at the counter electrode when insufficient oxygen is available for reduction, which thereby affects the counter electrode in that it is unable to balance the current coming from the working electrode. When insufficient oxygen is available for the counter electrode, the counter electrode can be driven in its electrochemical search for electrons all the way to its most negative value, which could be ground or 0.0 V, which causes the reference to shift, reducing the bias voltage, such is as described in more detail below. In other words, a common result of ischemia a drop off in sensor current as a function of glucose concentration (for example, lower sensitivity). This happens because the working electrode no longer oxidizes all of the H2O2 arriving at its surface because of the reduced bias. In some extreme circumstances, an increase in glucose can produce no increase in current or even a decrease in current.

In some situations, transient ischemia can occur at high glucose levels, wherein oxygen can become limiting to the enzymatic reaction, resulting in a non-glucose dependent downward trend in the data. In some situations, certain movements or postures taken by the patient can cause transient signal artifacts as blood is squeezed out of the capillaries resulting in local ischemia and causing non-glucose dependent signal artifacts. In some situations, oxygen can also become transiently limited due to contracture of tissues around the sensor interface. This is similar to the blanching of skin that can be observed when one puts pressure on it. Under such pressure, transient ischemia can occur in both the epidermis and subcutaneous tissue. Transient ischemia is common and well tolerated by subcutaneous tissue. However, such ischemic periods can cause an oxygen deficit in implanted devices that can last for many minutes or even an hour or longer.

Although some examples of the effects of transient ischemia on a prior art glucose sensor are described above, similar effects can be seen with analyte sensors that use alternative catalysts to detect other analytes, for example, amino acids (amino acid oxidase), alcohol (alcohol oxidase), galactose (galactose oxidase), lactate (lactate oxidase), cholesterol (cholesterol oxidase), or the like.

Another problem with conventional electrochemical sensors is that they can electrochemically react not only with the analyte to be measured (or by-product of the enzymatic reaction with the analyte), but additionally can react with other electroactive species that are not intentionally being measured (for example, interfering species), which causes an increase in signal strength due to these “interfering species”. In other words, interfering species are compounds with an oxidation or reduction potential that overlaps with the analyte to be measured (or the by-product of the enzymatic reaction with the analyte). For example, in a conventional amperometric glucose oxidase-based glucose sensor wherein the sensor measures hydrogen peroxide, interfering species such as acetaminophen, ascorbate, and urate are known to produce inaccurate signal strength when they are not properly controlled.

Some conventional glucose sensors utilize a membrane system that blocks at least some interfering species, such as ascorbate and urate. In some such systems, at least one layer of the membrane system includes a porous structure that has a relatively impermeable matrix with a plurality of “micro holes” or pores of molecular dimensions, such that transfer through these materials is primarily due to passage of species through the pores (for example, the layer acts as a microporous barrier or sieve blocking interfering species of a particular size). In other such systems, at least one layer of the membrane system defines a permeability that allows selective dissolution and diffusion of species as solutes through the layer. Unfortunately, it is difficult to find membranes that are satisfactory or reliable in use, especially in vivo, which effectively block all interferants and/or interfering species in some embodiments.

Electrochemical Sensors of the Preferred Embodiments

In one aspect of the preferred embodiments, an electrochemical sensor is provided with an auxiliary electrode configured to generate oxygen in order to overcome the effects of transient ischemia. In another aspect of the preferred embodiments, an electrochemical sensor is provided with an auxiliary electrode configured to electrochemically modify (for example, oxidize or reduce) electrochemical interferants to render them substantially non-electroactively reactive at the electroactive sensing surface(s) in order to overcome the effects of interferants on the working electrode.

It is known that oxygen can be generated as a product of electrochemical reactions occurring at a positively charged electrode (for example, set at about +0.6 to about +1.2 V or more). One example of an oxygen producing reaction is the electrolysis of water, which creates oxygen at the anode (for example, the working electrode). In the exemplary electrochemical glucose sensor, glucose is converted to hydrogen peroxide by reacting with glucose oxidase and oxygen, after which the hydrogen peroxide is oxidized at the working electrode and oxygen is generated therefrom. It is noted that one challenge to generating oxygen electrochemically in this way is that while an auxiliary electrode does produce excess oxygen, the placement of the auxiliary electrode in proximity to the analyte-measuring working electrode can cause oxidation of hydrogen peroxide at the auxiliary electrode, resulting in reduced signals at the working electrode. It is also known that many electrochemical interferants can be reduced at a potential of from about +0.1V to +1.2V or more; for example, acetaminophen is reduced at a potential of about +0.4 V.

Accordingly, the sensors of preferred embodiments place an auxiliary electrode above the electrode system 16, or other electroactive sensing surface, thereby reducing or eliminating the problem of inaccurate signals as described above.

FIG. 4 is a side schematic illustration of a portion of the sensing region of an electrochemical sensor of the preferred embodiments, showing an auxiliary electrode between the enzyme and the outside solution while the working (sensing) electrode is located below the enzyme and further from the outside solution. Particularly, FIG. 4 shows an external solution 12, which represents the bodily or other fluid to which the sensor is exposed in vivo or in vitro.

The membrane system 18 includes a plurality of domains (for example, cell impermeable domain, resistance domain, enzyme domain, and/or other domains such as are described in U.S. Published Patent Application 2003/0032874 to Rhodes et al. and copending U.S. patent application Ser. No. 10/885,476, filed Jul. 6, 2004 and entitled, “SYSTEMS AND METHODS FOR MANUFACTURE OF AN ANALYTE-MEASURING DEVICE INCLUDING A MEMBRANE SYSTEM”, the contents of which are incorporated herein by reference in their entireties) is located proximal to the external solution and finctions to transport fluids necessary for the enzymatic reaction, while protecting inner components of the sensor from harsh biohazards, for example. Although each domain is not independently shown, the enzyme 38 is shown disposed between an auxiliary electrode 36 and the working electrode 16a in the illustrated embodiment.

Preferably, the auxiliary electrode 36 is located within or adjacent to the membrane system 18, for example, between the enzyme and other domains, although the auxiliary electrode can be placed anywhere between the electroactive sensing surface and the outside fluid. The auxiliary electrode 36 is formed from known working electrode materials (for example, platinum, palladium, graphite, gold, carbon, conductive polymer, or the like) and has a voltage setting that produces oxygen (for example, from about +0.6 V to +1.2 V or more) and/or that electrochemically modifies (for example, reduces) electrochemical interferants to render them substantially non-reactive at the electroactive sensing surface(s) (for example, from about +0.1 V to +1.2 V or more). The auxiliary electrode can be a mesh, grid, plurality of spaced wires or conductive polymers, or other configurations designed to allow analytes to penetrate therethrough.

In the aspect of the preferred embodiments wherein the auxiliary electrode 36 is configured to generate oxygen, the oxygen generated from the auxiliary electrode 36 diffuses upward and/or downward to be utilized by the enzyme 38 and/or the counter electrode (depending on the placement of the auxiliary electrode). Additionally, the analyte (for example, glucose) from the outside solution (diffuses through the auxiliary electrode 36) reacts with the enzyme 38 and produces a measurable product (for example, hydrogen peroxide). Therefore, the product of the enzymatic reaction diffuses down to the working electrode 16a for accurate measurement without being eliminated by the auxiliary electrode 36.

In one alternative embodiment, the auxiliary electrode 36 can be coated with a polymeric material, which is impermeable to glucose but permeable to oxygen. By this coating, glucose will not electroactively react at the auxiliary electrode 36, which can otherwise cause at least some of the glucose to pre-oxidize as it passes through the auxiliary electrode 36 (when placed above the enzyme), which can prevent accurate glucose concentration measurements at the working electrode in some sensor configurations. In one embodiment, the polymer coating comprises silicone, however any polymer that is selectively permeable to oxygen, but not glucose, can be used. The auxiliary electrode 16 can be coated by any known process, such as dip coating or spray coating, after which is can be blown, blotted, or the like to maintain spaces within the electrode for glucose transport.

In another alternative embodiment, the auxiliary electrode 36 can be coated with a polymeric material that is permeable to glucose and oxygen and can be placed between the enzyme and the outside fluid. Consequently, the polymeric coating will cause glucose from the outside fluid to electroactively react at the auxiliary electrode 36, thereby limiting the amount of glucose that passes into the enzyme 38, and thus reducing the amount of oxygen necessary to successfully react with all available glucose in the enzyme. The polymeric material can function in place of or in combination with the resistance domain in order to limit the amount of glucose that passes through the membrane system. This embodiment assumes a stoichiometric relationship between glucose oxidation and decreased sensor signal output, which can be compensated for by calibration in some sensor configurations. Additionally, the auxiliary electrode generates oxygen, further reducing the likelihood of oxygen becoming a rate-limiting factor in the enzymatic reaction and/or at the counter electrode, for example.

In another aspect of the preferred embodiments, the auxiliary electrode 36 is configured to electrochemically modify (for example, oxidize or reduce) electrochemical interferants to render them substantially non-reactive at the electroactive sensing surface(s). In these embodiments, which can be in addition to or alternative to the above-described oxygen-generating embodiments, a polymer coating is chosen to selectively allow interferants (for example, urate, ascorbate, and/or acetaminophen such as described in U.S. Pat. No. 6,579,690 to Bonnecaze, et al.) to pass through the coating and electrochemically react with the auxiliary electrode, which effectively pre-oxidizes the interferants, rendering them substantially non-reactive at the working electrode 16a. In one exemplary embodiment, silicone materials can be synthesized to allow the transport of oxygen, acetaminophen and other interferants, but not allow the transport of glucose. In some embodiments, the polymer coating material can be chosen with a molecular weight that blocks glucose and allows the transport of oxygen, urate, ascorbate, and acetaminophen. In another exemplary embodiment, silicone materials can be synthesized to allow the transport of oxygen, glucose, acetaminophen, and other interferants. In some embodiments, the polymer coating material is chosen with a molecular weight that allows the transport of oxygen, glucose, urate, ascorbate, and acetaminophen. The voltage setting necessary to react with interfering species depends on the target electrochemical interferants, for example, from about +0.1 V to about +1.2 V. In some embodiments, wherein the auxiliary electrode is set at a potential of from about +0.6 to about +1.2 V, both oxygen-generation and electrochemical interferant modification can be achieved. In some embodiments, wherein the auxiliary electrode is set at a potential below about +0.6 V, the auxiliary electrode will function mainly to electrochemically modify interferants, for example.

Therefore, the sensors of preferred embodiments reduce or eliminate oxygen deficiency problems within electrochemical sensors by producing oxygen at an auxiliary electrode located above the enzyme within an enzyme-based electrochemical sensor. Additionally or alternatively, the sensors of preferred embodiments reduce or eliminate interfering species problems by electrochemically reacting with interferants at the auxiliary electrode rendering them substantially non-reactive at the working electrode.

Methods and devices that are suitable for use in conjunction with aspects of the preferred embodiments are disclosed in co-pending U.S. patent application Ser. No. 10/842,716, filed May 10, 2004 and entitled, “MEMBRANE SYSTEMS INCORPORATING BIOACTIVE AGENTS”; co-pending U.S. patent application Ser. No. 10/838,912 filed May 3, 2004 and entitled, “IMPLANTABLE ANALYTE SENSOR”; U.S. patent application Ser. No. 10/789,359 filed Feb. 26, 2004 and entitled, “INTEGRATED DELIVERY DEVICE FOR A CONTINUOUS GLUCOSE SENSOR”; U.S. application Ser. No. 10/685,636 filed Oct. 28, 2003 and entitled, “SILICONE COMPOSITION FOR MEMBRANE SYSTEM”; U.S. application Ser. No. 10/648,849 filed Aug. 22, 2003 and entitled, “SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM”; U.S. application Ser. No. 10/646,333 filed Aug. 22, 2003 entitled, “OPTIMIZED SENSOR GEOMETRY FOR AN IMPLANTABLE GLUCOSE SENSOR”; U.S. application Ser. No. 10/647,065 filed Aug. 22, 2003 entitled, “POROUS MEMBRANES FOR USE WITH IMPLANTABLE DEVICES”; U.S. application Ser. No. 10/633,367 filed Aug. 1, 2003 entitled, “SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA”; U.S. Pat. No. 6,702,857 entitled “MEMBRANE FOR USE WITH IMPLANTABLE DEVICES”; U.S. application Ser. No. 09/916,711 filed Jul. 27, 2001 and entitled “SENSOR HEAD FOR USE WITH IMPLANTABLE DEVICE”; U.S. application Ser. No. 09/447,227 filed Nov. 22, 1999 and entitled “DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS”; U.S. application Ser. No. 10/153,356 filed May 22, 2002 and entitled “TECHNIQUES TO IMPROVE POLYURETHANE MEMBRANES FOR IMPLANTABLE GLUCOSE SENSORS”; U.S. application Ser. No. 09/489,588 filed Jan. 21, 2000 and entitled “DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS”; U.S. application Ser. No. 09/636,369 filed Aug. 11, 2000 and entitled “SYSTEMS AND METHODS FOR REMOTE MONITORING AND MODULATION OF MEDICAL DEVICES”; and U.S. application Ser. No. 09/916,858 filed Jul. 27, 2001 and entitled “DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS,” as well as issued patents including U.S. Pat. No. 6,001,067 issued Dec. 14, 1999 and entitled “DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS”; U.S. Pat. No. 4,994,167 issued Feb. 19, 1991 and entitled “BIOLOGICAL FLUID MEASURING DEVICE”; and U.S. Pat. No. 4,757,022 filed Jul. 12, 1988 and entitled “BIOLOGICAL FLUID MEASURING DEVICE”; U.S. application Ser. No. 60/489,615 filed Jul. 23, 2003 and entitled “ROLLED ELECTRODE ARRAY AND ITS METHOD FOR MANUFACTURE”; U.S. application Ser. No. 60/490,010 filed Jul. 25, 2003 and entitled “INCREASING BIAS FOR OXYGEN PRODUCTION IN AN ELECTRODE ASSEMBLY”; U.S. application Ser. No. 60/490,009 filed Jul. 25, 2003 and entitled “OXYGEN ENHANCING ENZYME MEMBRANE FOR ELECTROCHEMICAL SENSORS”; U.S. application Ser. No. 60/490,007 filed Jul. 25, 2003 and entitled “OXYGEN-GENERATING ELECTRODE FOR USE IN ELECTROCHEMICAL SENSORS”; U.S. application Ser. No. 10/896,637 filed Jul. 21, 2004 and entitled “ROLLED ELECTRODE ARRAY AND ITS METHOD FOR MANUFACTURE”; U.S. application Ser. No. 10/896,772 filed Jul. 21, 2004 and entitled “INCREASING BIAS FOR OXYGEN PRODUCTION IN AN ELECTRODE SYSTEM”; U.S. application Ser. No. 10/896,639 filed Jul. 21, 2004 and entitled “OXYGEN ENHANCING MEMBRANE SYSTEMS FOR IMPLANTABLE DEVICES”; U.S. application Ser. No. 10/897,377 filed Jul. 21, 2004 and entitled “ELECTROCHEMICAL SENSORS INCLUDING ELECTRODE SYSTEMS WITH INCREASED OXYGEN GENERATION”. The foregoing patent applications and patents are incorporated herein by reference in their entireties.

All references cited herein are incorporated herein by reference in their entireties. To the extent publications and patents or patent applications incorporated by reference contradict the disclosure contained in the specification, the specification is intended to supersede and/or take precedence over any such contradictory material.

The term “comprising” as used herein is synonymous with “including,” “containing,” or “characterized by,” and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps.

All numbers expressing quantities of ingredients, reaction conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth in the specification and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by the present invention. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should be construed in light of the number of significant digits and ordinary rounding approaches.

The above description discloses several methods and materials of the present invention. This invention is susceptible to modifications in the methods and materials, as well as alterations in the fabrication methods and equipment. Such modifications will become apparent to those skilled in the art from a consideration of this disclosure or practice of the invention disclosed herein. Consequently, it is not intended that this invention be limited to the specific embodiments disclosed herein, but that it cover all modifications and alternatives coming within the true scope and spirit of the invention as embodied in the attached claims.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US156464110 Apr 19228 Dec 1925Chicago Miniature Lamp WorksDetector for wireless systems
US24023067 Oct 194318 Jun 1946Turkel HenryRetaining guard guide for needles
US321057812 Jan 19625 Oct 1965Westinghouse Electric CorpMultispeed motor connector
US338137127 Sep 19657 May 1968Sanders Associates IncMethod of constructing lightweight antenna
US377518225 Feb 197227 Nov 1973Du PontTubular electrochemical cell with coiled electrodes and compressed central spindle
US382624420 Jul 197330 Jul 1974Us Health Education & WelfareThumbtack microelectrode and method of making same
US383803331 Aug 197224 Sep 1974Hoffmann La RocheEnzyme electrode
US39335939 Aug 197220 Jan 1976Beckman Instruments, Inc.Rate sensing batch analysis method
US398253022 Apr 197528 Sep 1976Egon StorchPenial appliance
US405275414 Jul 197611 Oct 1977Homsy Charles AImplantable structure
US406732228 Jan 197610 Jan 1978Johnson Joseph HDisposable, pre-gel body electrodes
US419784029 Sep 197615 Apr 1980Bbc Brown Boveri & Company, LimitedPermanent magnet device for implantation
US424088924 Jan 197923 Dec 1980Toyo Boseki Kabushiki KaishaEnzyme electrode provided with immobilized enzyme membrane
US425550029 Mar 197910 Mar 1981General Electric CompanyVibration resistant electrochemical cell having deformed casing and method of making same
US432425725 Feb 198013 Apr 1982U.S. Philips CorporationDevice for the transcutaneous measurement of the partial oxygen pressure in blood
US4374013 *3 Mar 198115 Feb 1983Enfors Sven OlofOxygen stabilized enzyme electrode
US437801615 Jul 198129 Mar 1983Biotek, Inc.Artificial endocrine gland containing hormone-producing cells
US438816615 May 198214 Jun 1983Tokyo Shibaura Denki Kabushiki KaishaElectrochemical measuring apparatus provided with an enzyme electrode
US440269416 Jul 19816 Sep 1983Biotek, Inc.Body cavity access device containing a hormone source
US44181485 Nov 198129 Nov 1983Miles Laboratories, Inc.Multilayer enzyme electrode membrane
US443100427 Oct 198114 Feb 1984Bessman Samuel PImplantable glucose sensor
US4431507 *12 Jan 198214 Feb 1984Matsushita Electric Industrial Co., Ltd.Enzyme electrode
US444284130 Apr 198117 Apr 1984Mitsubishi Rayon Company LimitedElectrode for living bodies
US447731420 Jul 198316 Oct 1984Siemens AktiengesellschaftMethod for determining sugar concentration
US448498719 May 198327 Nov 1984The Regents Of The University Of CaliforniaMethod and membrane applicable to implantable sensor
US449495019 Jan 198222 Jan 1985The Johns Hopkins UniversityPlural module medication delivery system
US454538222 Oct 19828 Oct 1985Genetics International, Inc.Sensor for components of a liquid mixture
US457129212 Aug 198218 Feb 1986Case Western Reserve UniversityApparatus for electrochemical measurements
US457821512 Aug 198325 Mar 1986Micro-Circuits CompanyElectrical conductivity-enhancing and protecting material
US465054720 Dec 198517 Mar 1987The Regents Of The University Of CaliforniaMethod and membrane applicable to implantable sensor
US46558801 Aug 19837 Apr 1987Case Western Reserve UniversityApparatus and method for sensing species, substances and substrates using oxidase
US467128813 Jun 19859 Jun 1987The Regents Of The University Of CaliforniaElectrochemical cell sensor for continuous short-term use in tissues and blood
US467297029 Jul 198516 Jun 1987Mitsubishi Rayon Company, Ltd.Electrode for living body
US468026818 Sep 198514 Jul 1987Children's Hospital Medical CenterImplantable gas-containing biosensor and method for measuring an analyte such as glucose
US46854633 Apr 198611 Aug 1987Williams R BruceDevice for continuous in vivo measurement of blood glucose concentrations
US47037566 May 19863 Nov 1987The Regents Of The University Of CaliforniaComplete glucose monitoring system with an implantable, telemetered sensor module
US47112457 May 19848 Dec 1987Genetics International, Inc.Sensor for components of a liquid mixture
US47216777 May 198726 Jan 1988Children's Hospital Medical CenterImplantable gas-containing biosensor and method for measuring an analyte such as glucose
US47263814 Jun 198623 Feb 1988Solutech, Inc.Dialysis system and method
US475049628 Jan 198714 Jun 1988Xienta, Inc.Method and apparatus for measuring blood glucose concentration
US475702219 Nov 198712 Jul 1988Markwell Medical Institute, Inc.Biological fluid measuring device
US476365829 Jul 198716 Aug 1988Solutech, Inc.Dialysis system 2nd method
US47769441 Sep 198711 Oct 1988Jiri JanataChemical selective sensors utilizing admittance modulated membranes
US47817988 May 19871 Nov 1988The Regents Of The University Of CaliforniaTransparent multi-oxygen sensor array and method of using same
US47866572 Jul 198722 Nov 1988Minnesota Mining And Manufacturing CompanyPolyurethanes and polyurethane/polyureas crosslinked using 2-glyceryl acrylate or 2-glyceryl methacrylate
US479554224 Apr 19863 Jan 1989St. Jude Medical, Inc.Electrochemical concentration detector device
US481342423 Dec 198721 Mar 1989University Of New MexicoLong-life membrane electrode for non-ionic species
US48223364 Mar 198818 Apr 1989Ditraglia JohnBlood glucose level sensing
US485861529 Jul 198822 Aug 1989Sentron V.O.F.Catheter sensor and memory unit
US486183022 Jun 198729 Aug 1989Th. Goldschmidt AgPolymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming
US48714406 Jul 19883 Oct 1989Daiken Industries, Ltd.Biosensor
US48830579 Sep 198628 Nov 1989Research Foundation, The City University Of New YorkCathodic electrochemical current arrangement with telemetric application
US488674028 May 198612 Dec 1989Imperial Chemical Industries PlcEnzyme-electrode sensor with organosilane treated membrane
US489062017 Feb 19882 Jan 1990The Regents Of The University Of CaliforniaTwo-dimensional diffusion glucose substrate sensing electrode
US489062119 Jan 19882 Jan 1990Northstar Research Institute, Ltd.Continuous glucose monitoring and a system utilized therefor
US490990827 Oct 198820 Mar 1990Pepi RossElectrochemical cncentration detector method
US49191414 Jan 198824 Apr 1990Institute fur Diabetestechnologie Gemeinnutzige Forschungs- und Entwicklungsgesellschaft mbHImplantable electrochemical sensor
US492740719 Jun 198922 May 1990Regents Of The University Of MinnesotaCardiac assist pump with steady rate supply of fluid lubricant
US495355221 Apr 19894 Sep 1990Demarzo Arthur PBlood glucose monitoring system
US495586121 Apr 198811 Sep 1990Therex Corp.Dual access infusion and monitoring system
US497014520 Jan 198813 Nov 1990Cambridge Life Sciences PlcImmobilized enzyme electrodes
US49733202 Aug 198827 Nov 1990Firma Carl FreudenbergTissue-compatible medical device and method for manufacturing the same
US497492928 Mar 19904 Dec 1990Baxter International, Inc.Fiber optical probe connector for physiologic measurement devices
US497517515 Jun 19894 Dec 1990Isao KarubeMiniaturized oxygen electrode and miniaturized biosensor and production process thereof
US499279410 Oct 198912 Feb 1991Texas Instruments IncorporatedTransponder and method for the production thereof
US49941677 Jul 198819 Feb 1991Markwell Medical Institute, Inc.Biological fluid measuring device
US503033314 Oct 19869 Jul 1991Children's Hospital Medical CenterPolarographic method for measuring both analyte and oxygen with the same detecting electrode of an electroenzymatic sensor
US503411216 May 198923 Jul 1991Nissan Motor Company, Ltd.Device for measuring concentration of nitrogen oxide in combustion gas
US505061212 Sep 198924 Sep 1991Matsumura Kenneth NDevice for computer-assisted monitoring of the body
US506308115 Aug 19905 Nov 1991I-Stat CorporationMethod of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
US508911211 Jan 199018 Feb 1992Associated Universities, Inc.Electrochemical biosensor based on immobilized enzymes and redox polymers
US514098521 Oct 199125 Aug 1992Schroeder Jon MNoninvasive blood glucose measuring device
US515514910 Oct 199113 Oct 1992Boc Health Care, Inc.Silicone polyurethane copolymers containing oxygen sensitive phosphorescent dye compounds
US51654079 Apr 199124 Nov 1992The University Of KansasImplantable glucose sensor
US517168918 Apr 198915 Dec 1992Matsushita Electric Industrial Co., Ltd.Solid state bio-sensor
US518354926 Jan 19902 Feb 1993Commtech International Management CorporationMulti-analyte sensing electrolytic cell
US519004127 Dec 19912 Mar 1993Palti Yoram ProfSystem for monitoring and controlling blood glucose
US51987713 Sep 199130 Mar 1993Transducer Research, Inc.Potentiostatic apparatus and methods
US52000517 Nov 19896 Apr 1993I-Stat CorporationWholly microfabricated biosensors and process for the manufacture and use thereof
US520226118 Nov 199113 Apr 1993Miles Inc.Conductive sensors and their use in diagnostic assays
US521205015 Aug 199018 May 1993Mier Randall MMethod of forming a permselective layer
US524283521 Jul 19927 Sep 1993Radiometer A/SMethod and apparatus for determining the concentration of oxygen
US524957624 Oct 19915 Oct 1993Boc Health Care, Inc.Universal pulse oximeter probe
US525043914 Dec 19925 Oct 1993Miles Inc.Use of conductive sensors in diagnostic assays
US526617919 Jul 199130 Nov 1993Matsushita Electric Industrial Co., Ltd.Quantitative analysis method and its system using a disposable sensor
US528131929 Jun 199225 Jan 1994Agency Of Industrial Science And TechnologyCarbon micro-sensor electrode and method for preparing it
US528284819 Apr 19931 Feb 1994Meadox Medicals, Inc.Self-supporting woven vascular graft
US528414011 Feb 19928 Feb 1994Eli Lilly And CompanyAcrylic copolymer membranes for biosensors
US528636429 Mar 199115 Feb 1994Rutgers UniversitySurface-modified electochemical biosensor
US529814415 Sep 199229 Mar 1994The Yellow Springs Instrument Company, Inc.Chemically wired fructose dehydrogenase electrodes
US529957122 Jan 19935 Apr 1994Eli Lilly And CompanyApparatus and method for implantation of sensors
US530726317 Nov 199226 Apr 1994Raya Systems, Inc.Modular microprocessor-based health monitoring system
US531046931 Dec 199110 May 1994Abbott LaboratoriesBiosensor with a membrane containing biologically active material
US531236110 Aug 199217 May 1994Zadini Filiberto PAutomatic cannulation device
US53220634 Oct 199121 Jun 1994Eli Lilly And CompanyHydrophilic polyurethane membranes for electrochemical glucose sensors
US533063428 Aug 199219 Jul 1994Via Medical CorporationCalibration solutions useful for analyses of biological fluids and methods employing same
US53377477 Jan 199316 Aug 1994Frederic NeftelImplantable device for estimating glucose levels
US53523483 Nov 19924 Oct 1994Nova Biomedical CorporationMethod of using enzyme electrode
US53523518 Jun 19934 Oct 1994Boehringer Mannheim CorporationBiosensing meter with fail/safe procedures to prevent erroneous indications
US53544492 Jan 199211 Oct 1994Band David MpH electrode
US53721333 Feb 199313 Dec 1994N.V. Nederlandsche Apparatenfabriek NedapImplantable biomedical sensor device, suitable in particular for measuring the concentration of glucose
US538402827 Aug 199324 Jan 1995Nec CorporationBiosensor with a data memory
US538732719 Oct 19927 Feb 1995Duquesne University Of The Holy GhostImplantable non-enzymatic electrochemical glucose sensor
US539067115 Mar 199421 Feb 1995Minimed Inc.Transcutaneous sensor insertion set
US539125015 Mar 199421 Feb 1995Minimed Inc.Method of fabricating thin film sensors
US541164725 Jan 19942 May 1995Eli Lilly And CompanyTechniques to improve the performance of electrochemical sensors
US541186630 Mar 19932 May 1995National Research Council Of CanadaMethod and system for determining bioactive substances
US542571712 Aug 199320 Jun 1995The Kendall CompanyEpidural catheter system utilizing splittable needle
US542812323 Apr 199327 Jun 1995The Polymer Technology GroupCopolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight range
US54311609 Nov 199311 Jul 1995University Of New MexicoMiniature implantable refillable glucose sensor and material therefor
US543898430 Mar 19938 Aug 1995Sudor PartnersApparatus and method for the collection of analytes on a dermal patch
US546264521 Sep 199231 Oct 1995Imperial College Of Science, Technology & MedicineDialysis electrode device
US546657510 Sep 199214 Nov 1995I-Stat CorporationProcess for the manufacture of wholly microfabricated biosensors
US546984627 Sep 199428 Nov 1995Duquesne University Of The Holy GhostImplantable non-enzymatic electrochemical glucose sensor
US547455227 Jun 199412 Dec 1995Cb-Carmel Biotechnology Ltd.Implantable drug delivery pump
US547609415 Nov 199319 Dec 1995Eli Lilly And CompanyAcrylic copolymer membranes for biosensors
US547677615 Jul 199419 Dec 1995University Of New MexicoImmobilized enzymes for use in an electrochemical sensor
US548200811 Sep 19929 Jan 1996Stafford; Rodney A.Electronic animal identification system
US54824739 May 19949 Jan 1996Minimed Inc.Flex circuit connector
US548677629 Sep 199423 Jan 1996Xilinx, Inc.Antifuse-based programmable logic circuit
US549456227 Jun 199427 Feb 1996Ciba Corning Diagnostics Corp.Electrochemical sensors
US549645312 Oct 19945 Mar 1996Kyoto Daiichi Kagaku Co., Ltd.Biosensor and method of quantitative analysis using the same
US549777219 Nov 199312 Mar 1996Alfred E. Mann Foundation For Scientific ResearchGlucose monitoring system
US550239621 Sep 199426 Mar 1996Asulab S.A.Measuring device with connection for a removable sensor
US55072883 May 199516 Apr 1996Boehringer Mannheim GmbhAnalytical system for monitoring a substance to be analyzed in patient-blood
US550850930 Nov 199316 Apr 1996Minnesota Mining And Manufacturing CompanySensing elements and methods for uniformly making individual sensing elements
US553187813 May 19932 Jul 1996The Victoria University Of ManchesterSensor devices
US556443927 Dec 199415 Oct 1996George J. PichaInfusion device for soft tissue
US556880616 Feb 199529 Oct 1996Minimed Inc.Transcutaneous sensor insertion set
US556918625 Apr 199429 Oct 1996Minimed Inc.Closed loop infusion pump system with removable glucose sensor
US556946231 Mar 199529 Oct 1996Baxter International Inc.Methods for enhancing vascularization of implant devices
US55713954 Nov 19945 Nov 1996Goldstar Co., Ltd.Breath alcohol analyzer using a biosensor
US55759306 Oct 199319 Nov 1996Tietje-Girault; JordisMethod of making gas permeable membranes for amperometric gas electrodes
US558218411 Oct 199410 Dec 1996Integ IncorporatedInterstitial fluid collection and constituent measurement
US558249727 Jun 199410 Dec 1996Wing Labo Co., Ltd.Automatic warehouse system
US55938521 Sep 199414 Jan 1997Heller; AdamSubcutaneous glucose electrode
US560515218 Jul 199425 Feb 1997Minimed Inc.Optical glucose sensor
US560756527 Mar 19954 Mar 1997Coulter CorporationApparatus for measuring analytes in a fluid sample
US561190020 Jul 199518 Mar 1997Michigan State UniversityMicrobiosensor used in-situ
US562453720 Sep 199429 Apr 1997The University Of British Columbia - University-Industry Liaison OfficeBiosensor and interface membrane
US562889027 Sep 199513 May 1997Medisense, Inc.Electrochemical sensor
US56409545 May 199524 Jun 1997Pfeiffer; ErnstMethod and apparatus for continuously monitoring the concentration of a metabolyte
US56538639 May 19965 Aug 1997Bayer CorporationMethod for reducing bias in amperometric sensors
US566016318 May 199526 Aug 1997Alfred E. Mann Foundation For Scientific ResearchGlucose sensor assembly
US566522211 Oct 19959 Sep 1997E. Heller & CompanySoybean peroxidase electrochemical sensor
US56768203 Feb 199514 Oct 1997New Mexico State University Technology Transfer Corp.Remote electrochemical sensor
US568288427 Jul 19944 Nov 1997Medisense, Inc.Strip electrode with screen printing
US568682918 May 199511 Nov 1997Metrohm AgVoltammetric method and apparatus
US570335929 Jul 199630 Dec 1997Leybold Inficon, Inc.Composite membrane and support assembly
US570435423 Jun 19956 Jan 1998Siemens AktiengesellschaftElectrocatalytic glucose sensor
US570680711 Oct 199613 Jan 1998Applied Medical ResearchSensor device covered with foam membrane
US570750212 Jul 199613 Jan 1998Chiron Diagnostics CorporationSensors for measuring analyte concentrations and methods of making same
US571186122 Nov 199527 Jan 1998Ward; W. KennethDevice for monitoring changes in analyte concentration
US573527312 Sep 19957 Apr 1998Cygnus, Inc.Chemical signal-impermeable mask
US57413307 Jun 199521 Apr 1998Baxter International, Inc.Close vascularization implant material
US57416346 Jun 199521 Apr 1998A & D Company LimitedThrowaway type chemical sensor
US574689812 Nov 19925 May 1998Siemens AktiengesellschaftElectrochemical-enzymatic sensor
US574983228 Jan 199312 May 1998The Victoria University Of ManchesterMonitoring systems
US57566322 Jun 199526 May 1998The Polymer Technology GroupSystems for premeating molecules of predetermined molecular weight range
US577632417 May 19967 Jul 1998Encelle, Inc.Electrochemical biosensors
US577706026 Sep 19967 Jul 1998Minimed, Inc.Silicon-containing biocompatible membranes
US57913444 Jan 199611 Aug 1998Alfred E. Mann Foundation For Scientific ResearchPatient monitoring system
US579545323 Jan 199618 Aug 1998Gilmartin; Markas A. T.Electrodes and metallo isoindole ringed compounds
US579577410 Jul 199718 Aug 1998Nec CorporationBiosensor
US580042019 Dec 19961 Sep 1998Elan Medical Technologies LimitedAnalyte-controlled liquid delivery device and analyte monitor
US58073752 Nov 199515 Sep 1998Elan Medical Technologies LimitedAnalyte-controlled liquid delivery device and analyte monitor
US582062218 Dec 199613 Oct 1998Elan Medical Technologies LimitedAnalyte-controlled liquid delivery device and analyte monitor
US583360313 Mar 199610 Nov 1998Lipomatrix, Inc.Implantable biosensing transponder
US58374547 Jun 199517 Nov 1998I-Stat CorporationProcess for the manufacture of wholly microfabricated biosensors
US584014830 Jun 199524 Nov 1998Bio Medic Data Systems, Inc.Method of assembly of implantable transponder
US58511975 Feb 199722 Dec 1998Minimed Inc.Injector for a subcutaneous infusion set
US586340012 Apr 199526 Jan 1999Usf Filtration & Separations Group Inc.Electrochemical cells
US587937322 Dec 19959 Mar 1999Boehringer Mannheim GmbhSystem and method for the determination of tissue properties
US588249428 Aug 199516 Mar 1999Minimed, Inc.Polyurethane/polyurea compositions containing silicone for biosensor membranes
US589523525 Mar 199620 Apr 1999Em Microelectronic-Marin SaProcess for manufacturing transponders of small dimensions
US59140266 Jan 199722 Jun 1999Implanted Biosystems Inc.Implantable sensor employing an auxiliary electrode
US592813016 Mar 199827 Jul 1999Schmidt; BrunoApparatus and method for implanting radioactive seeds in tissue
US594466116 Apr 199731 Aug 1999Giner, Inc.Potential and diffusion controlled solid electrolyte sensor for continuous measurement of very low levels of transdermal alcohol
US59546439 Jun 199721 Sep 1999Minimid Inc.Insertion set for a transcutaneous sensor
US595495420 Jun 199721 Sep 1999Suprex CorporationMethod and apparatus for determination of analyte concentration
US59578545 Dec 199728 Sep 1999Besson; MarcusWireless medical diagnosis and monitoring equipment
US596313211 Oct 19965 Oct 1999Avid Indentification Systems, Inc.Encapsulated implantable transponder
US596499319 Dec 199612 Oct 1999Implanted Biosystems Inc.Glucose sensor
US596538012 Jan 199912 Oct 1999E. Heller & CompanySubcutaneous glucose electrode
US597219911 Feb 199726 Oct 1999E. Heller & CompanyElectrochemical analyte sensors using thermostable peroxidase
US598512928 Apr 199216 Nov 1999The Regents Of The University Of CaliforniaMethod for increasing the service life of an implantable sensor
US598940911 Sep 199523 Nov 1999Cygnus, Inc.Method for glucose sensing
US599984812 Sep 19977 Dec 1999Alfred E. Mann FoundationDaisy chainable sensors and stimulators for implantation in living tissue
US60010674 Mar 199714 Dec 1999Shults; Mark C.Device and method for determining analyte levels
US601198421 Nov 19964 Jan 2000Minimed Inc.Detection of biological molecules using chemical amplification and optical sensors
US60131136 Mar 199811 Jan 2000Wilson Greatbatch Ltd.Slotted insulator for unsealed electrode edges in electrochemical cells
US603082723 Jan 199829 Feb 2000I-Stat CorporationMicrofabricated aperture-based sensor
US60497273 Apr 199811 Apr 2000Animas CorporationImplantable sensor and system for in vivo measurement and control of fluid constituent levels
US60513897 Nov 199718 Apr 2000Radiometer Medical A/SEnzyme sensor
US605994613 Apr 19989 May 2000Matsushita Electric Industrial Co., Ltd.Biosensor
US606608327 Nov 199823 May 2000Syntheon LlcImplantable brachytherapy device having at least partial deactivation capability
US6066448 *6 Mar 199623 May 2000Meso Sclae Technologies, Llc.Multi-array, multi-specific electrochemiluminescence testing
US60817353 Jul 199727 Jun 2000Masimo CorporationSignal processing apparatus
US608173620 Oct 199727 Jun 2000Alfred E. Mann FoundationImplantable enzyme-based monitoring systems adapted for long term use
US608371016 Jun 19994 Jul 2000E. Heller & CompanyElectrochemical analyte measurement system
US608860820 Oct 199711 Jul 2000Alfred E. Mann FoundationElectrochemical sensor and integrity tests therefor
US60931562 Dec 199725 Jul 2000Abbott LaboratoriesMethod and apparatus for obtaining blood for diagnostic tests
US609317231 Dec 199725 Jul 2000Minimed Inc.Injector for a subcutaneous insertion set
US611729024 Jul 199812 Sep 2000Pepex Biomedical, LlcSystem and method for measuring a bioanalyte such as lactate
US611902820 Oct 199712 Sep 2000Alfred E. Mann FoundationImplantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces
US61206764 Jun 199919 Sep 2000Therasense, Inc.Method of using a small volume in vitro analyte sensor
US612100916 Jul 199919 Sep 2000E. Heller & CompanyElectrochemical analyte measurement system
US61225368 Jul 199619 Sep 2000Animas CorporationImplantable sensor and system for measurement and control of blood constituent levels
US61344614 Mar 199817 Oct 2000E. Heller & CompanyElectrochemical analyte
US61415734 Aug 199831 Oct 2000Cygnus, Inc.Chemical signal-impermeable mask
US614486911 May 19997 Nov 2000Cygnus, Inc.Monitoring of physiological analytes
US614487126 Mar 19997 Nov 2000Nec CorporationCurrent detecting sensor and method of fabricating the same
US61626113 Jan 200019 Dec 2000E. Heller & CompanySubcutaneous glucose electrode
US617575230 Apr 199816 Jan 2001Therasense, Inc.Analyte monitoring device and methods of use
US618953615 Apr 199920 Feb 2001Medtronic Inc.Method for protecting implantable devices
US621241622 May 19983 Apr 2001Good Samaritan Hospital And Medical CenterDevice for monitoring changes in analyte concentration
US623347111 May 199915 May 2001Cygnus, Inc.Signal processing for measurement of physiological analysis
US62480675 Feb 199919 Jun 2001Minimed Inc.Analyte sensor and holter-type monitor system and method of using the same
US625652217 Aug 19953 Jul 2001University Of Pittsburgh Of The Commonwealth System Of Higher EducationSensors for continuous monitoring of biochemicals and related method
US625993719 Jun 199810 Jul 2001Alfred E. Mann FoundationImplantable substrate sensor
US6264825 *23 Jun 199924 Jul 2001Clinical Micro Sensors, Inc.Binding acceleration techniques for the detection of analytes
US626816130 Sep 199831 Jul 2001M-Biotech, Inc.Biosensor
US627428512 Nov 199914 Aug 2001Agfa-Gevaert NvRadiation-sensitive recording material for the production of driographic offset printing plates
US627571723 Jun 199814 Aug 2001Elan Corporation, PlcDevice and method of calibrating and testing a sensor for in vivo measurement of an analyte
US62844784 Dec 19964 Sep 2001E. Heller & CompanySubcutaneous glucose electrode
US62858977 Apr 19994 Sep 2001Endonetics, Inc.Remote physiological monitoring system
US629392518 Dec 199825 Sep 2001Minimed Inc.Insertion device for an insertion set and method of using the same
US629428130 Nov 199825 Sep 2001Therasense, Inc.Biological fuel cell and method
US630000216 Aug 19999 Oct 2001Moltech Power Systems, Inc.Notched electrode and method of making same
US630952626 Aug 199930 Oct 2001Matsushita Electric Industrial Co., Ltd.Biosensor
US632597915 Oct 19974 Dec 2001Robert Bosch GmbhDevice for gas-sensoring electrodes
US632916122 Sep 200011 Dec 2001Therasense, Inc.Subcutaneous glucose electrode
US634322514 Sep 199929 Jan 2002Implanted Biosystems, Inc.Implantable glucose sensor
US635677616 Aug 200012 Mar 2002Cygnus, Inc.Device for monitoring of physiological analytes
US636088810 Feb 200026 Mar 2002Minimed Inc.Glucose sensor package system
US636679419 Nov 19992 Apr 2002The University Of ConnecticutGeneric integrated implantable potentiostat telemetry unit for electrochemical sensors
US63681412 Jul 19999 Apr 2002Vanantwerp Nannette M.Insertion set for a transcutenous sensor with cable connector lock mechanism
US63682748 May 20009 Apr 2002Medtronic Minimed, Inc.Reusable analyte sensor site and method of using the same
US640097429 Jun 20004 Jun 2002Sensors For Medicine And Science, Inc.Implanted sensor processing system and method for processing implanted sensor output
US640719525 Apr 199618 Jun 20023M Innovative Properties CompanyTackified polydiorganosiloxane oligourea segmented copolymers and a process for making same
US640967424 Sep 199825 Jun 2002Data Sciences International, Inc.Implantable sensor with wireless communication
US64133937 Jul 19992 Jul 2002Minimed, Inc.Sensor including UV-absorbing polymer and method of manufacture
US641833224 Feb 20009 Jul 2002MinimedTest plug and cable for a glucose monitor
US642484723 Feb 200023 Jul 2002Medtronic Minimed, Inc.Glucose monitor calibration methods
US644241315 May 200027 Aug 2002James H. SilverImplantable sensor
US644744830 Dec 199910 Sep 2002Ball Semiconductor, Inc.Miniature implanted orthopedic sensors
US645471011 Apr 200124 Sep 2002Motorola, Inc.Devices and methods for monitoring an analyte
US645991722 May 20001 Oct 2002Ashok GowdaApparatus for access to interstitial fluid, blood, or blood plasma components
US646149627 Oct 19998 Oct 2002Therasense, Inc.Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US646681028 Nov 200015 Oct 2002Legacy Good Samaritan Hospital And Medical CenterImplantable device for monitoring changes in analyte concentration
US648404510 Feb 200019 Nov 2002Medtronic Minimed, Inc.Analyte sensor and method of making the same
US648404610 Jul 200019 Nov 2002Therasense, Inc.Electrochemical analyte sensor
US64989419 Mar 200024 Dec 2002Advanced Cardiovascular Systems, Inc.Catheter based probe and method of using same for detecting chemical analytes
US651032924 Jan 200121 Jan 2003Datex-Ohmeda, Inc.Detection of sensor off conditions in a pulse oximeter
US651293927 Jun 200028 Jan 2003Medtronic Minimed, Inc.Implantable enzyme-based monitoring systems adapted for long term use
US651471829 Nov 20014 Feb 2003Therasense, Inc.Subcutaneous glucose electrode
US65203269 Oct 200118 Feb 2003Medtronic Minimed, Inc.Glucose sensor package system
US653471114 Apr 199818 Mar 2003The Goodyear Tire & Rubber CompanyEncapsulation package and method of packaging an electronic circuit module
US654276510 Mar 19981 Apr 2003The Regent Of The University Of CaliforniaMethod for the iontophoretic non-invasive determination of the in vivo concentration level of an inorganic or organic substance
US65462682 Jun 20008 Apr 2003Ball Semiconductor, Inc.Glucose sensor
US654783923 Jan 200115 Apr 2003Skc Co., Ltd.Method of making an electrochemical cell by the application of polysiloxane onto at least one of the cell components
US65514966 Mar 200122 Apr 2003Ysi IncorporatedMicrostructured bilateral sensor
US655324130 Aug 200122 Apr 2003Mallinckrodt Inc.Oximeter sensor with digital memory encoding sensor expiration data
US655832020 Jan 20006 May 2003Medtronic Minimed, Inc.Handheld personal data assistant (PDA) with a medical device and method of using the same
US655832111 Aug 20006 May 2003Dexcom, Inc.Systems and methods for remote monitoring and modulation of medical devices
US65583511 Jun 20006 May 2003Medtronic Minimed, Inc.Closed loop system for controlling insulin infusion
US65604712 Jan 20016 May 2003Therasense, Inc.Analyte monitoring device and methods of use
US656550921 Sep 200020 May 2003Therasense, Inc.Analyte monitoring device and methods of use
US657949822 Mar 200017 Jun 2003David EgliseImplantable blood glucose sensor system
US659591927 Feb 200122 Jul 2003Cygnus, Inc.Device for signal processing for measurement of physiological analytes
US661298428 Nov 20002 Sep 2003Kerr, Ii Robert A.System and method for collecting and transmitting medical data
US66133798 May 20012 Sep 2003Isense Corp.Implantable analyte sensor
US661507821 Apr 20002 Sep 2003Cygnus, Inc.Methods and devices for removing interfering species
US661893415 Jun 200016 Sep 2003Therasense, Inc.Method of manufacturing small volume in vitro analyte sensor
US664201529 Dec 20004 Nov 2003Minimed Inc.Hydrophilic polymeric material for coating biosensors
US665462516 Jun 200025 Nov 2003Therasense, Inc.Mass transport limited in vivo analyte sensor
US668926523 Mar 200110 Feb 2004Therasense, Inc.Electrochemical analyte sensors using thermostable soybean peroxidase
US669938328 May 20022 Mar 2004Siemens AktiengesellschaftMethod for determining a NOx concentration
US670285727 Jul 20019 Mar 2004Dexcom, Inc.Membrane for use with implantable devices
US672158715 Feb 200213 Apr 2004Regents Of The University Of CaliforniaMembrane and electrode structure for implantable sensor
US673020028 Apr 20004 May 2004Abbott LaboratoriesElectrochemical sensor for analysis of liquid samples
US673715830 Oct 200218 May 2004Gore Enterprise Holdings, Inc.Porous polymeric membrane toughened composites
US674187721 Jan 200025 May 2004Dexcom, Inc.Device and method for determining analyte levels
US67436351 Nov 20021 Jun 2004Home Diagnostics, Inc.System and methods for blood glucose sensing
US677356520 Jun 200110 Aug 2004Kabushiki Kaisha RikenNOx sensor
US67842746 Aug 200231 Aug 2004Minimed Inc.Hydrophilic, swellable coatings for biosensors
US67938024 Jan 200121 Sep 2004Tyson Bioresearch, Inc.Biosensors having improved sample application and measuring properties and uses thereof
US680104114 May 20025 Oct 2004Abbott LaboratoriesSensor having electrode for determining the rate of flow of a fluid
US680295728 Sep 200112 Oct 2004Marine Biological LaboratorySelf-referencing enzyme-based microsensor and method of use
US680950728 Dec 200126 Oct 2004Medtronic Minimed, Inc.Implantable sensor electrodes and electronic circuitry
US680965317 Dec 199926 Oct 2004Medtronic Minimed, Inc.Telemetered characteristic monitor system and method of using the same
US686246527 Jul 20011 Mar 2005Dexcom, Inc.Device and method for determining analyte levels
US688155128 Jan 200319 Apr 2005Therasense, Inc.Subcutaneous glucose electrode
US689131721 May 200210 May 2005Sri InternationalRolled electroactive polymers
US689208526 Nov 200210 May 2005Medtronic Minimed, Inc.Glucose sensor package system
US689355223 Oct 200117 May 2005Arrowhead Center, Inc.Microsensors for glucose and insulin monitoring
US68952638 May 200217 May 2005Medtronic Minimed, Inc.Real time self-adjusting calibration algorithm
US689526525 Jun 200217 May 2005James H. SilverImplantable sensor
US695260421 Dec 20014 Oct 2005Becton, Dickinson And CompanyMinimally-invasive system and method for monitoring analyte levels
US696579126 Mar 200315 Nov 2005Sorenson Medical, Inc.Implantable biosensor system, apparatus and method
US697208012 Jun 20006 Dec 2005Matsushita Electric Industrial Co., Ltd.Electrochemical device for moving particles covered with protein
US70033368 Feb 200121 Feb 2006Medtronic Minimed, Inc.Analyte sensor method of making the same
US700897927 Sep 20027 Mar 2006Hydromer, Inc.Coating composition for multiple hydrophilic applications
US70333228 Nov 200125 Apr 2006Silver James HImplantable sensor
US70705801 Apr 20034 Jul 2006Unomedical A/SInfusion device and an adhesive sheet material and a release liner
US707858221 Aug 200118 Jul 20063M Innovative Properties CompanyStretch removable adhesive articles and methods
US70811957 Dec 200425 Jul 2006Dexcom, Inc.Systems and methods for improving electrochemical analyte sensors
US71108039 Sep 200319 Sep 2006Dexcom, Inc.Device and method for determining analyte levels
US71158846 Oct 19973 Oct 2006Trustees Of Tufts CollegeSelf-encoding fiber optic sensor
US713499922 Aug 200314 Nov 2006Dexcom, Inc.Optimized sensor geometry for an implantable glucose sensor
US713668919 Jan 200514 Nov 2006Dexcom, Inc.Device and method for determining analyte levels
US715326522 Apr 200226 Dec 2006Medtronic Minimed, Inc.Anti-inflammatory biosensor for reduced biofouling and enhanced sensor performance
US71660742 Jun 200323 Jan 2007Medtronic Minimed, Inc.Reusable analyte sensor site and method of using the same
US719245022 Aug 200320 Mar 2007Dexcom, Inc.Porous membranes for use with implantable devices
US720797421 Feb 200324 Apr 2007Medtronic Minimed, Inc.Insertion device for an insertion set and method of using the same
US724890612 Dec 200224 Jul 2007Danfoss A/SMethod and device for monitoring analyte concentration by optical detection
US726766531 Dec 200211 Sep 2007Medtronic Minimed, Inc.Closed loop system for controlling insulin infusion
US72791748 May 20039 Oct 2007Advanced Cardiovascular Systems, Inc.Stent coatings comprising hydrophilic additives
US2002004256130 Nov 200111 Apr 2002Schulman Joseph H.Implantable sensor and integrity tests therefor
US2002008419628 Dec 20014 Jul 2002Therasense, Inc.Small volume in vitro analyte sensor and methods
US2002009999728 Sep 200125 Jul 2002Philippe PiretTurbocoding methods with a large minimum distance, and systems for implementing them
US200201197114 Jan 200229 Aug 2002Minimed, Inc.Insertion set for a transcutaneous sensor
US2002017776322 May 200128 Nov 2002Burns David W.Integrated lancets and methods
US2002018818512 Jun 200112 Dec 2002Borzu SohrabPercutaneous biological fluid sampling and analyte measurement devices and methods
US2003000445725 Jun 20022 Jan 2003Andersson Stig O.Hypodermic implant device
US2003000666921 May 20029 Jan 2003Sri InternationalRolled electroactive polymers
US2003000909325 Jun 20029 Jan 2003Silver James H.Implantable sensor
US2003003287427 Jul 200113 Feb 2003Dexcom, Inc.Sensor head for use with implantable devices
US200300367732 Aug 200220 Feb 2003Whitehurst Todd K.Systems and methods for treatment of coronary artery disease
US2003005054621 Jun 200213 Mar 2003Desai Shashi P.Methods for improving the performance of an analyte monitoring system
US2003006525431 Oct 20023 Apr 2003Alfred E. Mann Foundation For Scientific ResearchImplantable enzyme-based monitoring system having improved longevity due to improved exterior surfaces
US2003008816611 Nov 20028 May 2003Therasense, Inc.Electrochemical analyte sensor
US2003009708223 Dec 200222 May 2003Board Of Regents, The University Of Texas SystemMethods and apparatuses for navigating the subarachnoid space
US2003012561327 Dec 20013 Jul 2003Medtronic Minimed, Inc.Implantable sensor flush sleeve
US2003013061631 Dec 200210 Jul 2003Medtronic Minimed, Inc.Closed loop system for controlling insulin infusion
US2003013434728 Jan 200317 Jul 2003Therasense, Inc.Subcutaneous glucose electrode
US2003013867414 Nov 200224 Jul 2003Zeikus Gregory J.Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration
US2003018733818 Apr 20032 Oct 2003Therasense, Inc.Analyte monitoring device and methods of use
US2003019974514 May 200323 Oct 2003Cygnus, Inc.Methods and devices for removing interfering species
US200302034981 Nov 200230 Oct 2003Home Diagnostics, Inc.System and methods for blood glucose sensing
US200302110506 May 200313 Nov 2003The Procter & Gamble CompanyCompositions comprising anionic functionalized polyorganosiloxanes for hydrophobically modifying surfaces and enhancing delivery of active agents to surfaces treated therewith
US200302116251 Apr 200313 Nov 2003Cohan Bruce E.Method and apparatus for non-invasive monitoring of blood substances using self-sampled tears
US200302253243 Jun 20024 Dec 2003Anderson Edward J.Noninvasive detection of a physiologic Parameter within a body tissue of a patient
US200302254374 Apr 20034 Dec 2003Ferguson Patrick J.Device for retaining material
US2003023581721 Mar 200325 Dec 2003Miroslaw BartkowiakMicroprocessors, devices, and methods for use in analyte monitoring systems
US2004000626314 Feb 20038 Jan 2004Anderson Edward J.Noninvasive detection of a physiologic parameter within a body tissue of a patient
US2004001506321 Dec 200122 Jan 2004Denuzzio John D.Minimally-invasive system and method for monitoring analyte levels
US200400458799 Sep 200311 Mar 2004Dexcom, Inc.Device and method for determining analyte levels
US2004006316711 Jul 20031 Apr 2004Peter KaastrupMinimising calibration problems of in vivo glucose sensors
US2004007478518 Oct 200222 Apr 2004Holker James D.Analyte sensors and methods for making them
US2004007821921 Oct 200222 Apr 2004Kimberly-Clark Worldwide, Inc.Healthcare networks with biosensors
US2004010685720 Nov 20033 Jun 2004Regents Of The University Of CaliforniaMembrane and electrode structure for implantable sensor
US2004010685924 Nov 20033 Jun 2004James SayAnalyte monitoring device and methods of use
US2004011101725 Nov 200310 Jun 2004Therasense, Inc.Mass transport limited in vivo analyte sensor
US200401331645 Nov 20038 Jul 2004Funderburk Jeffery V.Sensor inserter device and methods of use
US2004013854327 Oct 200315 Jul 2004Russell Geoffrey A.Assembly of single use sensing elements
US200401431732 Jun 200322 Jul 2004Medtronic Minimed, Inc.Reusable analyte sensor site and method of using the same
US2004016780116 Feb 200426 Aug 2004James SayAnalyte monitoring device and methods of use
US2004017347228 Sep 20019 Sep 2004Marine Biological LaboratorySelf-referencing enzyme-based microsensor and method of use
US2004017667215 Jan 20049 Sep 2004Silver James H.Implantable, retrievable, thrombus minimizing sensors
US2004018039110 Oct 200316 Sep 2004Miklos GratzlSliver type autonomous biosensors
US200402196647 Jun 20044 Nov 2004Therasense, Inc.Electrodes with multilayer membranes and methods of using and making the electrodes
US200402240018 May 200311 Nov 2004Pacetti Stephen D.Stent coatings comprising hydrophilic additives
US2004023457515 Apr 200325 Nov 2004Roland HorresMedical products comprising a haemocompatible coating, production and use thereof
US2004023620024 Nov 200325 Nov 2004James SayAnalyte monitoring device and methods of use
US200402429826 Sep 20022 Dec 2004Tetsuya SakataMeasuring instrument, installation body, and density measurer
US2004025443312 Jun 200316 Dec 2004Bandis Steven D.Sensor introducer system, apparatus and method
US200500271801 Aug 20033 Feb 2005Goode Paul V.System and methods for processing analyte sensor data
US200500271811 Aug 20033 Feb 2005Goode Paul V.System and methods for processing analyte sensor data
US2005002718231 Dec 20033 Feb 2005Uzair SiddiquiSystem for monitoring physiological characteristics
US200500274631 Aug 20033 Feb 2005Goode Paul V.System and methods for processing analyte sensor data
US2005003168910 May 200410 Feb 2005Dexcom, Inc.Biointerface membranes incorporating bioactive agents
US2005003313214 May 200410 Feb 2005Shults Mark C.Analyte measuring device
US200500383323 Jun 200417 Feb 2005Frank SaidaraSystem for monitoring physiological characteristics
US2005004359822 Aug 200324 Feb 2005Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US2005005142721 Jul 200410 Mar 2005Brauker James H.Rolled electrode array and its method for manufacture
US2005005144021 Jul 200410 Mar 2005Simpson Peter C.Electrochemical sensors including electrode systems with increased oxygen generation
US2005005490921 Jul 200410 Mar 2005James PetisceOxygen enhancing membrane systems for implantable devices
US2005005655128 Jun 200217 Mar 2005Cranfield UniversityElectrochemical detection of analytes
US2005005655221 Jul 200417 Mar 2005Simpson Peter C.Increasing bias for oxygen production in an electrode system
US2005007077012 Dec 200231 Mar 2005Holger DiracMethod and device for monitoring analyte concentration by optical detection
US200500775846 Dec 200414 Apr 2005Uhland Scott A.Hermetically sealed microchip reservoir devices
US2005009060728 Oct 200328 Apr 2005Dexcom, Inc.Silicone composition for biocompatible membrane
US200500965192 Aug 20045 May 2005Denuzzio John D.Minimally-invasive system and method for monitoring analyte levels
US2005010362522 Dec 200419 May 2005Rathbun RhodesSensor head for use with implantable devices
US2005011216922 Aug 200326 May 2005Dexcom, Inc.Porous membranes for use with implantable devices
US2005011583221 Jul 20042 Jun 2005Simpson Peter C.Electrode systems for electrochemical sensors
US2005012132224 Jan 20059 Jun 2005Therasense, Inc.Analyte monitoring device and methods of use
US200501436353 Dec 200430 Jun 2005Kamath Apurv U.Calibration techniques for a continuous analyte sensor
US2005017613616 Nov 200411 Aug 2005Dexcom, Inc.Afinity domain for analyte sensor
US2005017703622 Dec 200411 Aug 2005Shults Mark C.Device and method for determining analyte levels
US2005018101211 Jan 200518 Aug 2005Sean SaintComposite material for implantable device
US2005018245111 Jan 200518 Aug 2005Adam GriffinImplantable device with improved radio frequency capabilities
US2005018395419 Apr 200525 Aug 2005Hitchcock Robert W.Implantable biosensor system, apparatus and method
US2005019255726 Feb 20041 Sep 2005DexcomIntegrated delivery device for continuous glucose sensor
US2005019755428 Feb 20058 Sep 2005Michael PolchaComposite thin-film glucose sensor
US2005021157123 Jun 200329 Sep 2005Jurgen SchuleinElectrochemical detection method and device
US200502158717 Dec 200429 Sep 2005Feldman Benjamin JAnalyte sensor, and associated system and method employing a catalytic agent
US200502424793 May 20043 Nov 2005Petisce James RImplantable analyte sensor
US200502457953 May 20043 Nov 2005Dexcom, Inc.Implantable analyte sensor
US200502457993 May 20043 Nov 2005Dexcom, Inc.Implantable analyte sensor
US2005025803721 Apr 200324 Nov 2005Kiamars HajizadehElectrochemical sensor
US2005026156320 May 200424 Nov 2005Peter ZhouTransducer for embedded bio-sensor using body energy as a power source
US200502729894 Jun 20048 Dec 2005Medtronic Minimed, Inc.Analyte sensors and methods for making and using them
US2006000339815 Jul 20055 Jan 2006Therasense, Inc.Subcutaneous glucose electrode
US200600150206 Jul 200419 Jan 2006Dexcom, Inc.Systems and methods for manufacture of an analyte-measuring device including a membrane system
US2006001502410 Mar 200519 Jan 2006Mark BristerTranscutaneous medical device with variable stiffness
US2006001670021 Jun 200526 Jan 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006001932710 Mar 200526 Jan 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006002018610 Mar 200526 Jan 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006002018710 Mar 200526 Jan 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006002018910 Mar 200526 Jan 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006002019110 Mar 200526 Jan 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006002019210 Mar 200526 Jan 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006003613910 Mar 200516 Feb 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006003614010 Mar 200516 Feb 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006003614110 Mar 200516 Feb 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006003614210 Mar 200516 Feb 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006003614310 Mar 200516 Feb 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006003614421 Jun 200516 Feb 2006Dexcom, Inc.Transcutaneous analyte sensor
US2006003614521 Jun 200516 Feb 2006Dexcom, Inc.Transcutaneous analyte sensor
US200600789087 Jun 200513 Apr 2006Pitner James BMultianalyte sensor
US2006007974016 Nov 200513 Apr 2006Silver James HSensors for detecting substances indicative of stroke, ischemia, or myocardial infarction
US2006014265122 Feb 200629 Jun 2006Mark BristerAnalyte sensor
US2006015518022 Feb 200613 Jul 2006Mark BristerAnalyte sensor
US2006017737930 Dec 200510 Aug 2006Soheil AsgariComposition comprising an agent providing a signal, an implant material and a drug
US2006018387114 Apr 200617 Aug 2006Ward Robert SBiosensor membrane material
US2006018398422 Feb 200617 Aug 2006Dobbles J MAnalyte sensor
US2006018398522 Feb 200617 Aug 2006Mark BristerAnalyte sensor
US2006018985625 Apr 200624 Aug 2006James PetisceOxygen enhancing membrane systems for implantable devices
US2006019502917 Jan 200631 Aug 2006Shults Mark CLow oxygen in vivo analyte sensor
US200601988643 May 20067 Sep 2006Mark ShultsBiointerface membranes incorporating bioactive agents
US2006020001925 Apr 20067 Sep 2006James PetisceOxygen enhancing membrane systems for implantable devices
US200602000202 May 20067 Sep 2006Mark BristerTranscutaneous analyte sensor
US200602000222 May 20067 Sep 2006Brauker James HOptimized sensor geometry for an implantable glucose sensor
US200602009702 May 200614 Sep 2006Mark BristerTranscutaneous analyte sensor
US200602045363 May 200614 Sep 2006Mark ShultsBiointerface membranes incorporating bioactive agents
US200602119212 May 200621 Sep 2006Brauker James HOptimized sensor geometry for an implantable glucose sensor
US2006022256618 Jan 20065 Oct 2006Brauker James HTranscutaneous analyte sensor
US200602241082 May 20065 Oct 2006Brauker James HOptimized sensor geometry for an implantable glucose sensor
US2006022951218 Jan 200612 Oct 2006Petisce James RCellulosic-based interference domain for an analyte sensor
US200602352852 May 200619 Oct 2006Mark BristerTranscutaneous analyte sensor
US2006025876114 Apr 200616 Nov 2006Robert BoockSilicone based membranes for use in implantable glucose sensors
US2006026383910 May 200623 Nov 2006Isense CorporationCombined drug delivery and analyte sensor apparatus
US2006027092223 May 200630 Nov 2006Brauker James HAnalyte sensor
US2006027092323 May 200630 Nov 2006Brauker James HAnalyte sensor
US2006027585716 May 20067 Dec 2006Kjaer ThomasEnzyme sensor with a cover membrane layer covered by a hydrophilic polymer
US2006027585916 May 20067 Dec 2006Kjaer ThomasEnzyme sensor including a water-containing spacer layer
US2006028930724 Aug 200528 Dec 2006University Of South FloridaEpoxy Enhanced Polymer Membrane to Increase Durability of Biosensors
US2007000713329 Mar 200611 Jan 2007Andre MangSensor with increased biocompatibility
US200700273844 Oct 20061 Feb 2007Mark BristerDual electrode system for a continuous analyte sensor
US200700273854 Oct 20061 Feb 2007Mark BristerDual electrode system for a continuous analyte sensor
US200700327174 Oct 20068 Feb 2007Mark BristerDual electrode system for a continuous analyte sensor
US2007003271810 Oct 20068 Feb 2007Shults Mark CDevice and method for determining analyte levels
US200700380441 Jun 200615 Feb 2007Dobbles J MAnalyte sensor
US2007004590223 May 20061 Mar 2007Brauker James HAnalyte sensor
US200700937044 Oct 200626 Apr 2007Mark BristerDual electrode system for a continuous analyte sensor
US2007013569813 Dec 200514 Jun 2007Rajiv ShahBiosensors and methods for making and using them
US200701638801 Mar 200719 Jul 2007Dexcom, Inc.Analyte sensor
US2007017370917 Jan 200726 Jul 2007Petisce James RMembranes for an analyte sensor
US2007017371017 Jan 200726 Jul 2007Petisce James RMembranes for an analyte sensor
US2007017371123 Sep 200526 Jul 2007Medtronic Minimed, Inc.Sensor with layered electrodes
US2007019788922 Feb 200623 Aug 2007Mark BristerAnalyte sensor
US2007020396623 Mar 200730 Aug 2007Dexcom, Inc.Transcutaneous analyte sensor
US2007020824611 Apr 20076 Sep 2007Brauker James HTranscutaneous analyte sensor
US2007021361127 Mar 200713 Sep 2007Simpson Peter CDual electrode system for a continuous analyte sensor
US200702154913 Apr 200720 Sep 2007Abbott Diabetes Care, Inc.Subcutaneous Glucose Electrode
US200702180973 Apr 200720 Sep 2007Abbott Diabetes Care, Inc.Subcutaneous Glucose Electrode
US200702279074 Apr 20064 Oct 2007Rajiv ShahMethods and materials for controlling the electrochemistry of analyte sensors
US200702328793 May 20074 Oct 2007Mark BristerTranscutaneous analyte sensor
US2007023533118 May 200711 Oct 2007Dexcom, Inc.Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US200702592171 May 20078 Nov 2007The Penn State Research FoundationMaterials and configurations for scalable microbial fuel cells
US2007027519314 Feb 200529 Nov 2007Desimone Joseph MFunctional Materials and Novel Methods for the Fabrication of Microfluidic Devices
US200702993856 Sep 200727 Dec 2007Microchips, Inc.Device for the controlled exposure of reservoir-based sensors
US200800216661 Oct 200724 Jan 2008Dexcom, Inc.System and methods for processing analyte sensor data
US200800273011 Nov 200631 Jan 2008Ward W KennethAnalyte sensing and response system
US2008003326929 Oct 20057 Feb 2008San Medi Tech (Huzhou) Co., Ltd.Catheter-free implantable needle biosensor
US2008003497210 Aug 200614 Feb 2008The Regents Of The University Of CaliforniaMembranes with controlled permeability to polar and apolar molecules in solution and methods of making same
US2008004582414 Jun 200721 Feb 2008Dexcom, Inc.Silicone composition for biocompatible membrane
US2008015410127 Sep 200726 Jun 2008Faquir JainImplantable Biosensor and Methods of Use Thereof
US2008018873111 Apr 20087 Aug 2008Dexcom, Inc.Transcutaneous analyte sensor
US2008019493511 Apr 200814 Aug 2008Dexcom, Inc.Transcutaneous analyte sensor
US2008019493817 Apr 200814 Aug 2008Dexcom, Inc.Transcutaneous medical device with variable stiffness
US200802080251 May 200828 Aug 2008Dexcom, Inc.Low oxygen in vivo analyte sensor
US2008021491511 Apr 20084 Sep 2008Dexcom, Inc.Transcutaneous analyte sensor
US2008021491828 Apr 20084 Sep 2008Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US2008024296111 Jun 20082 Oct 2008Dexcom, Inc.Transcutaneous analyte sensor
US2008026233430 Jun 200823 Oct 2008Animas Technologies, Llc.Method and device for predicting physiological values
US200802961551 May 20084 Dec 2008Dexcom, Inc.Low oxygen in vivo analyte sensor
US2008030636821 Aug 200811 Dec 2008Dexcom, Inc.System and methods for processing analyte sensor data
US2009001237920 Aug 20088 Jan 2009Dexcom, Inc.System and methods for processing analyte sensor data
US2009004505528 Oct 200819 Feb 2009Dexcom, Inc.Sensor head for use with implantable devices
US200900626334 Nov 20085 Mar 2009Dexcorn, Inc.Implantable analyte sensor
US200900763563 Nov 200819 Mar 2009Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US2009007636013 Sep 200719 Mar 2009Dexcom, Inc.Transcutaneous analyte sensor
US2009009943615 Dec 200816 Apr 2009Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US2009012487914 Jan 200914 May 2009Dexcom, Inc.Transcutaneous analyte sensor
US200901436605 Dec 20084 Jun 2009Dexcom, Inc.Transcutaneous analyte sensor
USRE3191629 Apr 198118 Jun 1985Becton Dickinson & CompanyElectrochemical detection cell
EP0098592A25 Jul 198318 Jan 1984Fujisawa Pharmaceutical Co., Ltd.Portable artificial pancreas
EP0127958B18 May 198411 Mar 1992MediSense, Inc.Sensor electrode systems
EP0284518B125 Mar 19887 Oct 1992Isao KarubeMiniaturized oxygen electrode and miniaturized biosensor and production process thereof
EP0320109A12 Nov 198814 Jun 1989MediSense, Inc.Improved sensing system
EP0353328A13 Aug 19887 Feb 1990Dräger Nederland B.V.A polarographic-amperometric three-electrode sensor
EP0390390A119 Mar 19903 Oct 1990Associated Universities, Inc.Electrochemical biosensor based on immobilized enzymes and redox polymers
EP0396788A18 May 198914 Nov 1990Dräger Nederland B.V.Process and sensor for measuring the glucose content of glucosecontaining fluids
EP0476980B117 Sep 19919 Apr 1997Fujitsu LimitedOxygen electrode and process for the production thereof
EP0534074B115 Jul 19926 Mar 1996Institut für Diabetestechnologie Gemeinnützige Forschungs - und Entwicklungsgesellschaft mbHMethod and instrument for testing the concentration of body fluid constituents
EP0535898B128 Sep 19925 Feb 1997Eli Lilly And CompanyHydrophilic polyurethane membranes for electrochemical glucose sensors
EP0539625A128 Oct 19915 May 1993Dräger Medical Electronics B.V.Electrochemical sensor for measuring the glucose content of glucose containing fluids
EP0817809B125 Mar 199631 Jul 2002Medtronic MiniMed, Inc.Homogenous polymer compositions containing silicone for biosensor membranes
EP0838230B122 Oct 199717 Sep 2003Terumo Kabushiki KaishaGuide wire
EP0967788A210 Feb 199929 Dec 1999Hewlett-Packard CompanyDynamic generation of multi-resolution and tile-based images from flat compressed images
EP1153571A13 May 200114 Nov 2001A. Menarini Industrie Farmaceutiche Riunite S.R.L.Apparatus for measurement and control of the content of glucose, lactate or other metabolites in biological fluids
FR2656423A1 Title not available
FR2760962B1 Title not available
GB1442303A Title not available
JP62083649A Title not available
JP62083849A Title not available
JP63067560A Title not available
WO2001068901A216 Mar 200120 Sep 2001Roche Diagnostics GmbhImplantable analyte sensor
WO2001088524A110 May 200122 Nov 2001Therasense, Inc.Electrodes with multilayer membranes and methods of using and making the electrodes
WO2004021877A14 Sep 200218 Mar 2004Pendragon Medical Ltd.Method and device for measuring glucose
Non-Patent Citations
Reference
1Aalders et al. 1991. Development of a wearable glucose sensor; studies in healthy volunteers and in diabetic patients. The International Journal of Artificial Organs 14(2):102-108.
2Abe et al. 1992. Characterization of glucose microsensors for intracellular measurements. Anal. Chem. 64(18):2160-2163.
3Abel et al. 1984. Experience with an implantable glucose sensor as a prerequisite of an artificial beta cell, Biomed. Biochim. Acta 43(5):577-584.
4Abel, P. U.; von Woedtke, T. Biosensors for in vivo glucose measurement: can we cross the experimental stage. Biosens Bioelectron 2002, 17, 1059-1070.
5Armour, et al. Dec. 1990. Application of Chronic Intravascular Blood Glucose Sensor in Dogs. Diabetes 39:1519-1526.
6Asberg et al. 2003. Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode. Biosensors Bioelectronics. pp. 199-207.
7Atanasov et al. 1994. Biosensor for continuous glucose monitoring. Biotechnology and Bioengineering 43:262-266.
8Atanasov et al. 1997. Implantation of a refillable glucose monitoring-telemetry device. Biosens Bioelectron 12:669-680.
9Aussedat, et al. 1997. A user-friendly method for calibrating a subcutaneous glucose sensor-based hypoglycaemic alarm. Biosensors & Bioelectronics 12(11):1061-1071.
10Baker et al. 1993. Dynamic concentration challenges for biosensor characterization. Biosensors & Bioelectronics, 8:433-441.
11Baker, et al. 1996. Dynamic delay and maximal dynamic error in continuous biosensors. Anal Chem 68(8):1292-1297.
12Bani Amer, M. M. 2002. An accurate amperometric glucose sensor based glucometer with eliminated cross-sensitivity. J Med Eng Technol 26(5):208-213.
13Bard et al. 1980. Electrochemical Methods. John Wiley & Sons, pp. 173-175.
14Beach et al. 1999. Subminiature implantable potentiostat and modified commercial telemetry device for remote glucose monitoring. IEEE Transactions on Instrumentation and Measurement 48(6):1239-1245.
15Bellucci et al. Jan. 1986. Electrochemical behaviour of graphite-epoxy composite materials (GECM) in aqueous salt solutions, Journal of Applied Electrochemistry, 16(1):15-22.
16Bessman et al., Progress toward a glucose sensor for the artificial pancreas, Proceedings of a Workshop on Ion-Selective Microelectrodes, Jun. 4-5, 1973, Boston, MA, 189-197.
17Bindra et al. 1989. Pulsed amperometric detection of glucose in biological fluids at a surface-modified gold electrode. Anal Chem, 61:2566-2570.
18Bindra et al. 1991. Design and in Vitro Studies of a Needle-Type Glucose Senso for Subcutaneous Monitoring. Anal. Chem 63:1692-96.
19Bisenberger et al. 1995. A triple-step potential waveform at enzyme multisensors with thick-film gold electrodes for detection of glucose and sucrose. Sensors and Actuators, B 28:181-189.
20Bode, B. W. 2000. Clinical utility of the continuous glucose monitoring system. Diabetes Technol Ther, 2(Suppl 1):S35-41.
21Bott, A. 1998. Electrochemical methods for the determination of glucose. Current Separations, 17(1)25-31.
22Bott, A. W. 1997. A comparison of cyclic voltammetry and cyclic staircase voltammetry. Current Separations, 16(1):23-26.
23 *Bott, A.W. 1997. A Comparison of cyclic voltammetry and staircase voltammetry. Current Separations, 16(1):23-26.
24Bowman,et al. 1986. The packaging of implantable integrated sensors. IEEE Trans Biomed Eng BME33(2):248-255.
25Brooks, et al. "Development of an on-line glucose sensor for fermentation monitoring," Biosensors, 3:45-56 (1987/88).
26CAI et al. 2004. A wireless, remote query glucose biosensor based on a pH-sensitive polymer. Anal Chem 76(4):4038-4043.
27Campanella et al. 1993. Biosensor for direct determination of glucose and lactate in undiluted biological fluids. Biosensors & Bioelectronics 8:307-314.
28Cass et al. "Ferrocene-mediated enzyme electrodes for amperometric determination of glucose," Anal. Chem., 36:667-71 (1984).
29Cassidy et al., Apr. 1993. Novel electrochemical device for the detection of cholesterol or glucose, Analyst, 118:415-418.
30Chen et al. 2006. A noninterference polypyrrole glucose biosensor. Biosensors and Bioelectronics 22:639-643.
31Chia et al. 2004. Glucose sensors: toward closed loop insulin delivery. Endocrinol Metab Clin North Am 33:175-95.
32Choleau et al. 2002. Calibration of a subcutaneo amperometric glucose sensor. Part 1. Effect of measurement uncertainties on the determination of sensor sensitivity and background current. Biosensors and Bioelectronics, 17:641-646.
33Choleau, et al. 2002. Calibration of a subcutaneous amperometric glucose sensor implanted for 7 days in diabetic patients. Part 2. Superiority of the one-point calibration method. Biosensors and Bioelectronics 17:647-654.
34Claremont et al. Jul. 1986. Potentially-implantable, ferrocene-mediated glucose sensor. J. Biomed. Eng. 8:272-274.
35Clark et al. 1981. One-minute electrochemical enzymic assay for cholesterol in biological materials, Clin. Chem. 27(12):1978-1982.
36Clark et al. 1987. Configurational cyclic voltammetry: increasing the specificity and reliablity of implanted electrodes, IEEE/Ninth Annual Conference of the Engineering in Medicine and Biology Society, pp. 0782-0783.
37Clark et al. 1988. Long-term stability of electroenzymatic glucose sensors implanted in mice. Trans Am Soc Artif Intern Organs 34:259-265.
38CLSI. Performance metrics for continuous interstitial glucose monitoring; approved guideline, CLSI document POCT05-A. Wayne, PA: Clinical and Laboratory Standards Institute: 2008 28(33), 72 pp.
39Csoregi et al., 1994. Design, characterization, and one-point in vivo calibration of a subcutaneously implanted glucose electrode. Anal Chem. 66(19):3131-3138.
40Danielsson et al. 1988. Enzyme thermistors, Methods in Enzymology, 137:181-197.
41Davies, et al. 1992. Polymer membranes in clinical sensor applications. I. An overview of membrane function, Biomaterials, 13(14):971-978.
42Davis et al. 1983. Bioelectrochemical fuel cell and sensor based on a quinoprotein, alcohol dehydrogenase. Enzyme Microb. Technol., vol. 5, September, 383-388.
43Dixon et al. 2002. Characterization in vitro and in vivo of the oxygen dependence of an enzyme/polymer biosensor for monitoring brain glucose. Journal of Neuroscience Methods, 119:135-142.
44Durliat et al. 1976. Spectrophotometric and electrochemical determinations of L(+)-lactate in blood by use of lactate dehydrogenase from yeast, Clin. Chem. 22(11):1802-1805.
45El Deheigy et al. 1986. Optimization of an implantable coated wire glucose sensor. J. Biomed Eng. 8: 121-129.
46Fare et al. 1998. Functional characterization of a conducting polymer-based immunoassay system. Biosensors & Bioelectronics 13(3-4):459-470.
47Feldman et al. 2003. A continuous glucose sensor based on wired enzyme technology—results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther 5(5):769-779.
48Fischer et al. 1989. Oxygen Tension at the Subcutaneous Implantation Site of Glucose Sensors. Biomed. Biochem 11/12:965-972.
49Fischer et al. 1995. Hypoglycaemia-warning by means of subcutaneous electrochemical glucose sensors: an animal study, Horm. Metab. Rese. 27:53.
50Frohnauer, et al. 2001. Graphical human insulin time-activity profiles using standardized definitions. Diabetes Technology & Therapeutics 3(3):419-429.
51Frost, et al. 2002. Implantable chemical sensors for real-time clinical monitoring: Progress and challenges. Current Opinion in Chemical Biology 6:633-641.
52Ganesh et al., Evaluation of the VIA® blood chemistry monitor for glucose in healthy and diabetic volunteers, Journal of Diabetese Science and Technology, 2(2):182-193, Mar. 2008.
53Gilligan et al. Feasibility of continuous long-term glucose monitoring from a subcutaneous glucose sensor in humans. Diabetes Technol. Ther. 2004, 6, 378-386.
54Gilligan, B. C.; Shults, M.; Rhodes, R. K.; Jacobs, P. G.; Brauker, J. H.; Pintar, T. J.; Updike, S. J. Feasibility of continuo long-term glucose monitoring from a subcutaneous glucose sensor in humans. Diabetes Technol. Ther. 2004, 6, 378-386.
55Godsland, et al. 2001. Maximizing the Success Rate of Minimal Model Insulin Sensitivity Measurement in Humans: The Importance of Basal Glucose Levels. The Biochemical Society and the Medical Research Society, 1-9.
56Hall et al. 1998. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part 1. An adsorption-controlled mechanism. Electrochimica Acta, 43(5-6):579-588.
57Hall et al. 1998. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part II: Effect of potential. Electrochimica Acta; 43(14-15):2015-2024.
58Hall et al. 1999. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part III: Effect of temperature. Electrochimica Acta, 44:2455-2462.
59Hall et al. 1999. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part IV: Phosphate buffer dependence. Electrochimica Acta, 44:4573-4582.
60Hall et al. 2000. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part V: Inhibition by chloride. Electrochimica Acta, 45:3573-3579.
61Hashiguchi et al. (1994). "Development of a miniaturized glucose monitoring system by combining a needle-type glucose sensor with microdialysis sampling method: Long-term subcutaneous tissue glucose monitoring in ambulatory diabetic patients," Diabetes Care, 17(5): 387-396.
62Heller, "Electrical wiring of redox enzymes," Acc. Chem. Res., 23:128-134 (1990).
63Heller, A. 1992. Electrical Connection of Enzyme Redox Centers to Electrodes. J. Phys. Chem. 96:3579-3587.
64Heller, A. 2003. Plugging metal connectors into enzymes. Nat Biotechnol 21:631-2.
65Heller, A. Implanted electrochemical glucose sensors for the management of diabetes. Annu Rev Biomed Eng 1999, 1, 153-175.
66Hicks, 1985. In Situ Monitoring, Clinical Chemistry, 31(12):1931-1935.
67Hitchman, M. L. 1978. "Measurement of Dissolved Oxygen." In Elving et al. (Eds.). Chemical Analysis, vol. 49, Chap. 3, pp. 34-49, 59-123. New York: John Wiley & Sons.
68Hu, et al. 1993. A needle-type enzyme-based lactate sensor for in vivo monitoring, Analytica Chimica Acta, 281:503-511.
69Huang et al. Electrochemical Generation of Oxygen. 1: The Effects of Anions and Cations on Hydrogen Chemisorption and Aniodic Oxide Film Formation on Platinum Electrode. 2: The Effects of Anions and Cations on Oxygen Generation on Platinum Electrode, pp. 1-116, Aug. 1975.
70IPRP for PCT/US04/024178 filed Jul. 21, 2004.
71ISR and WO for PCT/US04/024178 filed Jul. 21, 2004.
72Jablecki et al. 2000. Simulations of the frequency response of Implantable glucose sensors. Analytical Chemistry, 72:1853-1859.
73Jaremko et al. 1998. Advances toward the implantable artificial pancreas for treatment of diabetes. Diabetes Care, 21(3):444-450.
74Jensen et al. 1997. Fast wave forms for pulsed electrochemical detection of glucose by incorporation of reductive desorption of oxidation products. Analytical Chemistry, 69(9):1776-1781.
75Johnson (1991). "Reproducible electrodeposition of biomolecules for the fabrication of miniature electroenzymatic biosensors," Sensors and Actuators B, 5:85-89.
76Johnson et al. 1992. In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue. Biosensors & Bioelectronics, 7:709-714.
77Kacaniklic, May-Jun. 1994. Electroanalysis, 6(5-6):381-390.
78Kang et al. In vitro and short-term in vivo characteristics of a Kel-F thin film modified glucose sensor. Anal Sci 2003, 19, 1481-1486.
79Kang, S. K.; Jeong, R.A.; Park, S.; Chung, T. D.; Park, S.; Kim, H.C. In vitro and short-term in vivo characteristics of a Kel-F thin film modified glucose sensor. Anal Sci 2003, 19, 1481-1486.
80Karube et al. 1993. Microbiosensors for acetylcholine and glucose. Biosensors & Bioelectronics 8:219-228.
81Kawagoe et al. 1991. Enzyme-modified organic conducting salt microelectrode, Anal. Chem. 63:2961-2965.
82Keedy et al. 1991. Determination of urate in undiluted whole blood by enzyme electrode. Biosensors & Bioelectronics, 6: 491-499.
83Kerner et al. 1988. A potentially implantable enzyme electrode for amperometric measurement of glucose, Horm Metab Res Suppl. 20:8-13.
84Kerner, et al. "The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma," Biosensors & Bioelectronics, 8:473-482 (1993).
85Ko, Wen H. 1985. Implantable Sensors for Closed-Loop Prosthetic Systems, Futura Pub. Co., Inc., Mt. Kisco, NY, Chapter 15:197-210.
86Kondo et al. 1982. A miniature glucose sensor, implantable in the blood stream. Diabetes Care. 5(3):218-221.
87Koschinsky, et al. 1998. New approach to technical and clinical evaluation of devices for self-monitoring of blood glucose. Diabetes Care 11(8): 619-619.
88Koudelka et al. 1989. In vivo response of microfabricated glucose sensors to glycemia changes in normal rats. Biomed Biochim Acta 48(11-12):953-956.
89Koudelka et al. 1991. In-vivo behaviour of hypodermically implanted microfabricated glucose sensors. Biosensors & Bioelectronics 6:31-36.
90Kraver et al. A mixed-signal sensor interface microinstrument. Sensors and Actuators A: Physical 2001, 91, 266-277.
91Kraver, K.; Gutha, M. R.; Strong, T.; Bird, P.; Cha, G.; Hoeld, W., Brown, R. A mixed-signal sensor interface microinstrument. Sensors and Actuators A: Physical 2001, 91, 266-277.
92LaCourse et al. 1993. Optimization of waveforms for pulsed amperometric detection of carbohydrates based on pulsed voltammetry. Analytical Chemistry, 65:50-52.
93Lerner et al. 1984. An implantable electrochemical glucose sensor. Ann. N. Y. Acad. Sci., 428:263-278.
94Leypoldt et al. 1984. Model of a two-substrate enzyme electrode for glucose. Anal. Chem., 56:2896-2904.
95Linke et al. 1994. Amperometric biosensor for in vivo glucose sensing based on glucose oxidase immobilized in a redox hydrogel. Biosensors & Bioelectronics 9:151-158.
96Lowe, 1984. Biosensors, Trends in Biotechnology, 2(3):59-65.
97Luong et al. 2004. Solubilization of Multiwall Carbon Nanotubes by 3-Aminopropyltriethoxysilane Towards the Fabrication of Electrochemical Biosensors with Promoted Electron Transfer. Electronanalysis 16(1-2):132-139.
98Maidan et al. 1992. Elimination of Electrooxidizable Interferent-Produced Currents in Amperometric Biosensors, Analytical Chemistry, 64:2889-2896.
99Makale et al. 2003. Tissue window chamber system for validation of implanted oxygen sensors. Am. J. Physiol. Heart Circ. Physiol. 284:H2288-2294.
100Mascini et al. 1989. Glucose electrochemical probe with extended linearity for whole blood. J Pharm Biomed Anal 7(12): 1507-1512.
101Mastrototaro, et al. "An electroenzymatic glucose sensor fabricated on a flexible substrate," Sensors and Actuators B, 5:139-44 (1991).
102Matthews et al. 1988. An amperometric needle-type glucose sensor testing in rats and man. Diabetic Medicine 5:248-252.
103McGrath et al. The use of differential measurements with a glucose biosensor for interference compensation during glucose determinations by flow injection analysis. Biosens Bioelectron 1995, 10, 937-943.
104McGrath, M. J.; Iwuoha, E. I.; Diamond, D.; Smyth, M. R. The use of differential measurements with a glucose biosensor for interference compensation during glucose determinations by flow injection analysis. Biosens Bioelectron 1995, 10, 937-943.
105McKean, et al. Jul. 7, 1988. A Telemetry Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors. Transactions on Biomedical Engineering 35:526-532.
106Memoli et al. A comparison between different immobilised glucoseoxidase-based electrodes. J Pharm Biomed Anal 2002, 29, 1045-1052.
107Moatti-Sirat et al., Reduction of acetaminophen interference in glucose sensors by a composite Nafion membrane: demonstration in rats and man, Diabetologia 37(6):610-616, Jun. 1994.
108Moatti-Sirat, D, et al. 1992. Evaluating in vitro and in vivo the interference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor. Biosensors and Bioelectronics 7:345-352.
109Morff et al. 1990. Microfabrication of reproducible, economical, electroenzymatic glucose sensors, Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 12(2):0483-0484.
110Mosbach et al. 1975. Determination of heat changes in the proximity of immobilized enzymes with an enzyme termistor and its use for the assay of metobolites, Biochim. Biophys. Acta. (Enzymology), 403:256-265.
111Motonaka et al. 1993. Determination of cholesteral and cholesteral ester with novel enzyme microsensors, Anal. Chem. 65:3258-3261.
112Mowery et al. 2000. Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials 21:9-21.
113Murphy, et al. 1992. Polymer membranes in clinical sensor applications. II. The design and fabrication of permselective hydrogels for electrochemical devices, Biomaterials, 13(14):979-990.
114Myler et al. 2002. Ultra-thin-polysiloxane-film-composite membranes for the optimisation of amperometric oxidase enzyme electrodes. Biosens Bioelectron 17:35-43.
115Neuburger et al. 1987. Pulsed amperometric detection of carbohydrates at gold electrodes with a two-step potential waveform. Anal. Chem., 59:150-154.
116Office Action dated Apr. 10, 2007 in U.S. Appl. 11/077,714.
117Office Action dated Apr. 10, 2007 in U.S. Appl. No. 11/077,715.
118Office Action dated Apr. 11, 2007 in U.S. Appl. No. 10/896,639.
119Office Action dated Apr. 12, 2010 in U.S. Appl. No. 11/333,837.
120Office Action dated Apr. 16, 2009 in U.S. Appl. 11/077,714.
121Office Action dated Apr. 21, 2008 in U.S. Appl. No. 11/077,643.
122Office Action dated Apr. 27, 2010 in U.S. Appl. No. 11/078,232.
123Office Action dated Apr. 4, 2006 in U.S. Appl. No. 09/447,227.
124Office Action dated Apr. 6, 2006 in U.S. Appl. No. 10/896,639.
125Office Action dated Apr. 6, 2009 in U.S. Appl. No. 11/077,883.
126Office Action dated Aug. 1, 2006 in U.S. Appl. No. 09/447,227.
127Office Action dated Aug. 11, 2008 in U.S. Appl. No. 11/360,819.
128Office Action dated Aug. 15, 2001 in U.S. Appl. No. 09/447,227.
129Office Action dated Aug. 22, 2006 in U.S. Appl. No. 10/896,639.
130Office Action dated Dec. 11, 2008 in U.S. Appl. No. 09/447,227.
131Office Action dated Dec. 12, 2007 in U.S. Appl. No. 11/543,707.
132Office Action dated Dec. 14, 2005 in U.S. Appl. No. 10/896,772.
133Office Action dated Dec. 23, 2004 in U.S. Appl. No. 09/916,711.
134Office Action dated Dec. 24, 2008 in U.S. Appl. No. 10/885,476.
135Office Action dated Dec. 26, 2007 in U.S. Appl. No. 11/021,046.
136Office Action dated Dec. 26, 2008 in U.S. Appl. No. 11/360,819.
137Office Action dated Dec. 3, 2008 in U.S. Appl. No. 11/675,063.
138Office Action dated Dec. 30, 2008 in U.S. Appl. No. 11/034,343.
139Office Action dated Dec. 7, 1998 in U.S. Appl. No. 08/811,473.
140Office Action dated Feb. 10, 2009 in U.S. Appl. No. 11/077,713.
141Office Action dated Feb. 11, 2004 in U.S. Appl. No. 09/916,711.
142Office Action dated Feb. 14, 2006 in U.S. Appl. No. 09/916,711.
143Office Action dated Feb. 19, 2010 in U.S. Appl. No. 11/675,063.
144Office Action dated Feb. 23, 2009 in U.S. Appl. No. 11/439,630.
145Office Action dated Feb. 23, 2010 in U.S. Appl. No. 12/113,508.
146Office Action dated Feb. 24, 2006 in U.S. Appl. No. 10/646,333.
147Office Action dated Feb. 4, 2009 in U.S. Appl. No. 11/021,046.
148Office Action dated Feb. 9, 2006 in U.S. Appl. No. 10/897,312.
149Office Action dated Jan. 10, 2008 in U.S. Appl. 11/077,714.
150Office Action dated Jan. 11, 2005 in U.S. Appl. No. 10/896,772.
151Office Action dated Jan. 15, 2008 in U.S. Appl. No. 11/034,344.
152Office Action dated Jan. 16, 2003 in U.S. Appl. No. 09/447,227.
153Office Action dated Jan. 17, 2002 in U.S. Appl. No. 09/447,227.
154Office Action dated Jan. 20, 2010 in U.S. Appl. No. 11/077,713.
155Office Action dated Jan. 22, 2009 in U.S. Appl. No. 11/692,154.
156Office Action dated Jan. 22, 2010 in U.S. Appl. No. 11/439,630.
157Office Action dated Jan. 23, 2008 in U.S. Appl. No. 09/447,227.
158Office Action dated Jan. 26, 2009 in U.S. Appl. No. 11/078,230.
159Office Action dated Jan. 27, 2006 in U.S. Appl. No. 11/007,635.
160Office Action dated Jan. 28, 2008 in U.S. Appl. No. 11/077,715.
161Office Action dated Jan. 29, 2009, in U.S. Appl. No. 11/360,252.
162Office Action dated Jan. 3, 2008 in U.S. Appl. No. 11/157,746.
163Office Action dated Jan. 30, 2007 in U.S. Appl. No. 11/077,763.
164Office Action dated Jan. 7, 2009 in U.S. Appl. No. 11/157,365.
165Office Action dated Jul. 1, 2005 in U.S. Appl. No. 09/916,711.
166Office Action dated Jul. 10, 2008 in U.S. Appl. No. 11/034,343.
167Office Action dated Jul. 10, 2008 in U.S. Appl. No. 11/077,759.
168Office Action dated Jul. 15, 2002 in U.S. Appl. No. 09/447,227.
169Office Action dated Jul. 16, 2008 in U.S. Appl. No. 10/838,912.
170Office Action dated Jul. 17, 2007 in U.S. Appl. No. 09/447,227.
171Office Action dated Jul. 19, 2005 in U.S. Appl. No. 10/896,772.
172Office Action dated Jul. 23, 2004 in U.S. Appl. No. 09/916,711.
173Office Action dated Jul. 26, 2007 in U.S. Appl. No. 11/077,715.
174Office Action dated Jul. 27, 2007 in U.S. Appl. 11/077,714.
175Office Action dated Jul. 9, 2003 in U.S. Appl. No. 09/447,227.
176Office Action dated Jun. 10, 2009 in U.S. Appl. No. 11/675,063.
177Office Action dated Jun. 12, 2008 in U.S. Appl. No. 09/447,227.
178Office Action dated Jun. 19, 2008 in U.S. Appl. No. 11/021,162.
179Office Action dated Jun. 23, 2008 in U.S. Appl. No. 11/021,046.
180Office Action dated Jun. 24, 2008 in U.S. Appl. No. 11/077,883.
181Office Action dated Jun. 24, 2010 in U.S. Appl. No. 12/113,724.
182Office Action dated Jun. 26, 2008 in U.S. Appl. No. 11/157,365.
183Office Action dated Jun. 29, 2009 in U.S. Appl. No. 11/333,837.
184Office Action dated Jun. 30, 2008 in U.S. Appl. No. 11/078,230.
185Office Action dated Jun. 30, 2008 in U.S. Appl. No. 11/360,252.
186Office Action dated Jun. 6, 2005 in U.S. Appl. No. 10/646,333.
187Office Action dated Mar. 11, 2009 in U.S. Appl. No. 11/077,643.
188Office Action dated Mar. 11, 2010 in U.S. Appl. No. 11/280,672.
189Office Action dated Mar. 14, 2007 in U.S. Appl. No. 10/695,636.
190Office Action dated Mar. 24, 2008 in U.S. Appl. No. 10/838,912.
191Office Action dated Mar. 31, 2008 in U.S. Appl. No. 11/077,759.
192Office Action dated Mar. 4, 2009 in U.S. Appl. No. 10/991,353.
193Office Action dated Mar. 5, 2009 in U.S. Appl. No. 10/896,637.
194Office Action dated Mar. 5, 2009 in U.S. Appl. No. 11/078,232.
195Office Action dated Mar. 9, 2007 in U.S. Appl. No. 09/447,227.
196Office Action dated May 1, 2008 in U.S. Appl. No. 11/157,746.
197Office Action dated May 11, 2006 in U.S. Appl. No. 10/897,377.
198Office Action dated May 12, 2008 in U.S. Appl. No. 11/077,715.
199Office Action dated May 17, 2007 in U.S. Appl. No. 11/077,759.
200Office Action dated May 22, 2006 in U.S. Appl. No. 10/896,772.
201Office Action dated May 5, 2008 in U.S. Appl. No. 11/077,713.
202Office Action dated May 5, 2008 in U.S. Appl. No. 11/078,232.
203Office Action dated Nov. 1, 2007 in U.S. Appl. No. 11/034,343.
204Office Action dated Nov. 12, 2008 in U.S. Appl. No. 11/078,232.
205Office Action dated Nov. 12, 2008, 2008 in U.S. Appl. No. 11/077,715.
206Office Action dated Nov. 28, 2003 in U.S. Appl. No. 09/447,227.
207Office Action dated Nov. 28, 2008 in U.S. App. No. 11/333,837.
208Office Action dated Nov. 28, 2008 in U.S. App. No. 11/360,250.
209Office Action dated Oct. 1, 2008 in U.S. Appl. No. 11/077,643.
210Office Action dated Oct. 11, 2006 in U.S. Appl. 11/077,714.
211Office Action dated Oct. 18, 2005 in U.S. Appl. No. 10/897,377.
212Office Action dated Oct. 29, 2009 in U.S. Appl. No. 11/280,672.
213Office Action dated Oct. 31, 2006 in U.S. Appl. No. 11/077,715.
214Office Action dated Oct. 5, 2007 in U.S. Appl. No. 10/896,639.
215Office Action dated Oct. 8, 2008 in U.S. Appl. No. 10/896,637.
216Office Action dated Oct. 9, 2007 in U.S. Appl. No. 11/077,883.
217Office Action dated Sep. 12, 2008 in U.S. Appl. No. 10/991,353.
218Office Action dated Sep. 16, 2008 in U.S. Appl. 11/077,714.
219Office Action dated Sep. 18, 2007 in U.S. Appl. No. 11/078,230.
220Office Action dated Sep. 18, 2008 in U.S. Appl. No. 11/077,883.
221Office Action dated Sep. 18, 2008 in U.S. Appl. No. 11/439,630.
222Office Action dated Sep. 2, 2009 in U.S. Appl. No. 11/077,713.
223Office Action dated Sep. 2, 2009 in U.S. Appl. No. 11/078,072.
224Office Action dated Sep. 21, 2007 in U.S. Appl. No. 10/838,912.
225Office Action dated Sep. 22, 2004 in U.S. Appl. No. 10/646,333.
226Office Action dated Sep. 22, 2005 in U.S. Appl. No. 09/447,227.
227Office Action dated Sep. 23, 2005 in U.S. Appl. No. 10/896,639.
228Office Action dated Sep. 24, 2003 in U.S. Appl. No. 09/916,711.
229Office Action dated Sep. 5, 2006 in U.S. Appl. No. 09/916,711.
230Office Action dated Sep. 5, 2008 in U.S. Appl. No. 11/078,230.
231Office Action mailed Dec. 12, 2007 in U.S. Appl. No. 11/543,539.
232Office Action mailed Dec. 12, 2007 in U.S. Appl. No. 11/543,683.
233Office Action mailed Dec. 17, 2007 in U.S. Appl. No. 11/543,734.
234Office Action mailed Jun. 5, 2007 in U.S. Appl. No. 11/543,734.
235Office Action mailed Jun. 5, 2008 in U.S. Appl. No. 10/838,909.
236Office Action mailed Mar. 16, 2009 in U.S. Appl. No. 10/838,909.
237Office Action mailed May 18, 2007 in U.S. Appl. No. 11/543,683.
238Office Action mailed May 18, 2007 in U.S. Appl. No. 11/543,707.
239Office Action mailed May 23, 2007 in U.S. Appl. No. 11/543,539.
240Ohara et al. 1994. "Wired" enzyme electrodes for amperometric determination of glucose or lactate in the presence of interfering substances. Anal Chem 66:2451-2457.
241Okuda et al. 1971. Mutarotase effect on micro determinations of D-glucose and its anomers with β-D-glucose oxidase. Anal Biochem 43:312-315.
242Patel et al. 2003. Amperometric glucose sensors based on ferrocene containing polymeric electron transfer systems-a preliminary report. Biosens Bioelectron 18:1073-6.
243Pfeiffer, E.F. 1990. The glucose sensor: the missing link in diabetes therapy, Horm Metab Res Suppl. 24:154-164.
244Pickup et al. 1988. Progress towards in vivo glucose sensing with a ferrocene-mediated amperometric enzyme electrode. 34-36.
245Pickup et al. 1989. Potentially-implantable, amperometric glucose sensors with mediated electron transfer: improving the operating stability. Biosensors 4:109-119.
246Pickup et al. 1993. Developing glucose sensors for in vivo use. Elsevier Science Publishers Ltd (UK), TIBTECH vol. 11: 285-291.
247Pickup, et al. "Implantable glucose sensors: choosing the appropriate sensor strategy," Biosensors, 3:335-346 (1987/88).
248Pickup, et al. "In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer," Diabetologia, 32:213-217 (1989).
249Pishko, et al. "Amperometric glucose microelectrodes prepared through immobilization of glucose oxidase in redox hydrogels," Anal. Chem., 63:2268-72 (1991).
250Poitout, et al. 1991. In Vitro and In Vivo Evaluation in Dogs of a Miniaturized Glucose Sensor, ASAIO Transactions, 37:M298-M300.
251Poitout, et al. 1993. A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit. Diabetologia 36:658-663.
252Postlethwaite et al. 1996. Interdigitated array electrode as an alternative to the rotated ring-disk electrode for determination of the reaction products of dioxygen reduction. Analytical Chemistry, 68:2951-2958.
253Prabhu et al. 1981. Electrochemical studies of hydrogen peroxide at a platinum disc electrode, Electrochimica Acta 26(6):725-729.
254Quinn et al. 1997. Biocompatible, glucose-permeable hydrogel for in situ coating of implantable biosensors. Biomaterials 18:1665-1670.
255Rabah et al., 1991. Electrochemical wear of graphite anodes during electrolysis of brine, Carbon, 29(2):165-171.
256Rebrin et al. 1992. Subcutaenous glucose monitoring by means of electrochemical sensors: fiction or reality? J. Biomed. Eng. 14:33-40.
257Rebrin, et al. "Automated feedback control of subcutaneous glucose concentration in diabetic dogs," Diabetologia, 32:573-76 (1989).
258Rhodes et al. 1994. Prediction of pocket-portable and implantable glucose enzyme electrode performance from combined species permeability and digital simulation analysis. Analytical Chemistry, 66(9):1520-1529.
259Rhodes, et al. 1994 Prediction of pocket-portable and implantable glucose enzyme electrode performance from combined species permeability and digital simulation analysis. Analytical Chemistry, 66(9):1520-1529.
260Sakakida et al. 1992. Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentrations. Artif. Organs Today 2(2):145-158.
261Sansen et al. 1985. "Glucose sensor with telemetry system." in Ko, W. H. (Ed.). Implantable Sensors for Closed Loop Prosthetic Systems. Chap. 12, pp. 167-175, Mount Kisco, NY: Futura Publishing Co.
262Sansen et al. 1990. A smart sensor for the voltammetric measurement of oxygen or glucose concentrations. Sensors and Actuators, B 1:298-302.
263Sansen, et al. 1990. A smart sensor for the voltammetric measurement of oxygen or glucose concentrations. Sensors and Actuators, B 1:298-302.
264Schmidt et al. 1993. Glucose concentration in subcutaneous extracellular space. Diabetes Care 16(5):695-700.
265Schmidtke et al., Measurement and modeling of the transient difference between blood and subcutaneous glucose concentrations in the rat after injection of insulin. Proc Natl Aced Sci U S A 1998, 95, 294-299.
266Schoemaker et al. 2003. The SCGM1 system: Subcutaneous continuous glucose monitoring based on microdialysis technique. Diabetes Technology & Therapeutics 5(4):599-608.
267Schoonen et al. 1990 Development of a potentially wearable glucose sensor for patients with diabetes mellitus: design and in-vitro evaluation. Biosensors & Bioelectronics 5:37-46.
268Schuler et al. 1999. Modified gas-permeable silicone rubber membranes for covalent immobilisation of enzymes and their use in biosensor development. Analyst 124:1181-1184.
269Selam, J. L. 1997. Management of diabetes with glucose sensors and implantable insulin pumps. From the dream of the 60s to the realities of the 90s. ASAIO J, 43:137-142.
270Shaw, et al. "In vitro testing of a simply constructed, highly stable glucose sensor suitable for implantation in diabetic patients," Biosensors & Bioelectronics, 6:401-406 (1991).
271Shichiri et al. 1982. Wearable artificial endocrine pancrease with needle-type glucose sensor. Lancet 2:1129-1131.
272Shichiri et al. 1985. Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas in Implantable Sensors 197-210.
273Shichiri, et al. 1983. Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas. Diabetologia 24:179-184.
274Shichiri, et al. 1986. Telemetry Glucose Monitoring Device with Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals. Diabetes Care, Inc. 9(3):298-301.
275Shults, et al. 1994. A telemetry-instrumentation system for monitoring multiple subcutaneously implanted glucose sensors. IEEE Transactions on Biomedical Engineering 41(10):937-942.
276Sokol et al. 1980, Immobilized-enzyme rate-determination method for glucose analysis, Clin. Chem. 26(1):89-92.
277Stern et al., 1957. Electrochemical polarization: 1. A theoretical analysis of the shape of polarization curves, Journal of the Electrochemical Society, 104(1):56-63.
278Sternberg et al. 1988. Covalent enzyme coupling on cellulose acetate membranes for glucose sensor development. Anal. Chem. 69:2781-2786.
279Stokes. 1988. Polyether Polyurethanes: Biostable or Not? J. Biomat. Appl. 3:228-259.
280Thome et al. 1995. Can the decrease in subcutaneous glucose concentration precede the decrease in blood glucose level? Proposition for a push-pull kinetics hypothesis, Horm. Metab. Res. 27:53.
281Thomé-Duret et al. 1996. Modification of the sensitivity of glucose sensor implanted into subcutaneous tissue. Diabetes Metabolism, 22:174-178.
282Thome-Duret et al. 1996. Use of a subcutaneous glucose sensor to detect decreases in glucose concentration prior to observation in blood, Anal. Chem. 68:3822-3826.
283Thompson, et al., In Vivo Probes: Problems and Perspectives, Department of Chemistry, University of Toronto, Canada, pp. 255-261, 1986.
284Tierney et al. 2000. Effect of acetaminophen on the accuracy of glucose measurements obtained with the GlucoWatch biographer. Diabetes Technol Ther 2:199-207.
285Torjman et al., Glucose monitoring in acute care: technologies on the horizon, Journal of Deabetes Science and Technology, 2(2):178-181, Mar. 2008.
286Tse et al. 1987. Time-Dependent Inactivation of Immobilized Glucose Oxidase and Catalase. Biotechnol. Bioeng. 29:705-713.
287Turner and Pickup, "Diabetes mellitus: biosensors for research and management," Biosensors, 1:85-115 (1985).
288Turner, A.P.F. 1988. Amperometric biosensor based on mediator-modified electrodes. Methods in Enzymology 137:90-103.
289TURNERet al. 1984. Carbon Monoxide: Acceptor Oxidoreductase from Pseudomonas Thermocarboxydovorans Strain C2 and its use in a Carbon Monoxide Sensor. Analytica Chimica Acta, 163: 161-174.
290U.S. Appl. No. 09/447,227, filed Nov. 22, 2999.
291U.S. Appl. No. 10/838,658, filed May 3, 2004.
292U.S. Appl. No. 10/838,909, filed May 3, 2004.
293U.S. Appl. No. 10/838,912, filed May 3, 2004.
294U.S. Appl. No. 10/885,476, filed Jul. 6, 2004.
295U.S. Appl. No. 10/897,377, filed Jul. 21, 2004.
296Updike et al. 1967. The enzyme electrode. Nature, 214:986-988.
297Updike et al. 1988. Laboratory Evaluation of New Reusable Blood Glucose Sensor. Diabetes Care, 11:801-807.
298Updike et al. 2000. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 23(2):208-214.
299Updike, et al. 1979. Continuous glucose monitor based on an immobilized enzyme electrode detector. J Lab Clin Med, 93(4):518-527.
300Updike, et al. 1994 Enzymatic glucose sensor: Improved long-term performance in vitro and in vivo. ASAIO Journal, 40(2):157-163.
301Updike, et al. 1997. Principles of long-term fully impleated sensors with emphasis on radiotelemetric monitoring of blood glucose form inside a subcutaneous foreign body capsule (FBC). In Fraser, ed., Biosensors in the Body. New York. John Wiley & Sons, pp. 117-137.
302Vadgama, P. Nov. 1981. Enzyme electrodes as practical biosensors. Journal of Medical Engineering & Technology 5(6):293-298.
303Vadgama. 1988. Diffusion limited enzyme electrodes. NATO ASI Series: Series C, Math and Phys. Sci. 226:359-377.
304Velho et al. 1989. Strategies for calibrating a subcutaneous glucose sensor. Biomed Biochim Acta 48(11/12):957-964.
305Wagner, et al. 1998. Continuous amperometric monitoring of glucose in a brittle diabetic chimpanzee with a miniature subcutaneous electrode. Proc. Natl. Acad. Sci. A, 95:6379-6382.
306Wang et al. 1994. Highly Selective Membrane-Free, Mediator-Free Glucose Biosensor. Anal. Chem. 66:3600-3603.
307Wang et al. Improved ruggedness for membrane-based amperometric sensors using a pulsed amperometric method. Anal Chem 1997, 69, 4482-4489.
308Wang, X.; Pardue, H. L. Improved ruggedness for membrane-based amperometric sensors using a pulsed amperometric method. Anal Chem 1997, 69, 4482-4489.
309Ward et al. 2000. Rise in background current over time in a subcutaneous glucose sensor in the rabbit: Relevance to calibration and accuracy. Biosensors & Bioelectronics, 15:53-61.
310Ward et al. 2002. A new amperometric glucose microsensor: In vitro and short-term in vivo evaluation. Biosensors & Bioelectronics, 17:181-189.
311Ward et al. Understanding Spontaneous Output Fluctuations of an Amperometric Glucose Sensor: Effect of Inhalation Anesthesia and e of a Nonenzyme Containing Electrode. ASAIO Journal 2000, 540-546.
312Ward, et al. 1999. Assessment of chronically implanted subcutaneous glucose sensors in dogs: The effect of surrounding fluid masses. ASAIO Journal, 45:555-561.
313Ward, et al. 2000. Rise in background current over time in a subcutaneous glucose sensor in the rabbit: Relevance to calibration and accuracy. Biosensors & Bioelectronics, 15:53-61.
314Ward, et al. 2002. A new amperometric glucose microsensor: In vitro and short-term in vivo evaluation, Biosensors & Bioelectronics, 17:181-189.
315Ward, W. K.; Wood, M. D.; Troupe, J. E. Understanding Spontaneous Output Fluctuations of an Amperometric Glucose Sensor: Effect of Inhalation Anesthesia and e of a Nonenzyme Containing Electrode. ASAIO Journal 2000, 540-546.
316Wientjes, K. J. C. Development of a glucose sensor for diabetic patients. 2000.
317Wilkins et al. 1988. The coated wire electrode glucose sensor, Horm Metab Res Suppl., 20:50-55.
318Wilkins et al. 1995. Integrated implantable device for long-term glucose monitoring. Biosens. Bioelectron 10:485-494.
319Wilkins et al. Glucose monitoring: state of the art and future possibilities. Med Eng Phys 1995, 18, 273-288.
320Wilkins, et al. 1995. Integrated implantable device for long-term glucose monitoring. Biosens. Bioelectron., 10:485-494.
321Wilson et al. 1992. Progress toward the development of an implantable sensor for glucose. Clin. Chem., 38(9):1613-1617.
322 *Wilson, et al. 1992. Progress toward the development of an implantable sensor for glucose. Clin. Chem., 38(9):1613-1617.
323Wilson, et al. 2000. Enzyme-based biosensors for in vivo measurements. Chem. Rev., 100:2693-2704.
324Worsley et al., Measurement of glucose in blood with a phenylboronic acid optical sensor, Journal of Diabetes Science and Technology, 2(2):213-220, Mar. 2008.
325Wright et al., Bioelectrochemical dehalogenations via direct electrochemistry of poly(ethylene oxide)- modified myoglobin, Electrochemistry Communications 1 (1999) 603-611.
326Wu et al. 1999. In situ electrochemical oxygen generation with an immunoisolation device. Ann. N.Y. Acad. Sci., 875:105-125.
327Yamasaki, Yoshimitsu. Sep. 1984. The development of a needle-type glucose sensor for wearable artificial endocrine pancreas. Medical Journal of Osaka University 35(1-2):25-34.
328Yamasakiet al. 1989. Direct measurement of whole blood glucose by a needle-type sensor. Clinica Chimica Acta. 93:93-98.
329Yang et al (1996). "A glucose biosensor based on an oxygen electrode: In-vitro performances in a model buffer solution and in blood plasma," Biomedical Instrumentation & Technology, 30:55-61.
330Yang, et al. 2004. A Comparison of Physical Properties and Fuel Cell Performance of Nafion and Zirconium Phosphate/Nafion Composite Membranes. Journal Of Membrane Science 237:145-161.
331Yanget al. 1998. Development of needle-type glucose sensor with high selectivity. Science and Actuators B 46:249-256.
332Zamzow et al. 1990. Development and evaluation of a wearable blood glucose monitor, ASAIO Transactions; 36(3): pp. M588-M591.
333Zhang et al (1993). Electrochemical oxidation of H202 on Pt and Pt + Ir electrodes in physiological buffer and its applicability to H202-based biosensors. J. Electroanal. Chem., 345:253-271.
334Zhang et al. 1993. In vitro and in vivo evaluation of oxygen effects on a glucose oxidase based implantable glucose sensor. Analytica Chimica Acta, 281:513-520.
335Zhang et al. 1994. Elimination of the acetaminophen interference in an implantable glucose sensor. Analytical Chemistry 66(7):1183-1188.
336Zhang et al. 1994. Elimination of the acetaminophen interference in an implantable glucose sensor. Analytical Chemistry, 66(7):1183-1188.
337Zhu et al. (1994). "Fabrication and characterization of glucose sensors based on a microarray H202 electrode." Biosensors & Bioelectronics, 9: 295-300.
338Zhu et al. 2002. Planar amperometric glucose sensor based on glucose oxidase immobilized by chitosan film on prussian blue layer. Sensors, 2:127-136.
Classifications
U.S. Classification204/403.05, 204/403.11, 600/347, 600/345
International ClassificationA61B5/05, G01N27/327, G01N27/26, G01N27/416, G01N
Cooperative ClassificationA61B5/14865, A61B5/14532, C12Q1/001, G01N27/3274
European ClassificationG01N27/416, A61B5/1486B, A61B5/145G, C12Q1/00B
Legal Events
DateCodeEventDescription
17 Jun 2008ASAssignment
Owner name: DEXCOM, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SIMPSON, PETER C.;PETISCE, JAMES R.;CARR-BRENDEL, VICTORIA;AND OTHERS;SIGNING DATES FROM 20050103 TO 20050111;REEL/FRAME:021106/0346
15 Jul 2010ASAssignment
Owner name: DEXCOM, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SIMPSON, PETER C.;PETISCE, JAMES R.;CARR-BRENDEL, VICTORIA;AND OTHERS;SIGNING DATES FROM 20050103 TO 20050111;REEL/FRAME:024693/0657
2 Oct 2012CCCertificate of correction
13 Jan 2014FPAYFee payment
Year of fee payment: 8